Home Cart Sign in  
Chemical Structure| 147098-20-2 Chemical Structure| 147098-20-2

Structure of Rosuvastatin Calcium
CAS No.: 147098-20-2

Chemical Structure| 147098-20-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Rosuvastatin Calcium is a competitive and synthetic HMG-CoA reductase inhibitor with IC50 value of 11 nM.

Synonyms: Rosuvastatin hemicalcium; ZD 4522 Calcium; ZD 4522

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Rosuvastatin Calcium

CAS No. :147098-20-2
Formula : C44H54CaF2N6O12S2
M.W : 1001.14
SMILES Code : [O-]C(C[C@@H](C[C@@H](/C=C/C1=C(N=C(N=C1C2=CC=C(C=C2)F)N(S(=O)(C)=O)C)C(C)C)O)O)=O.[O-]C(C[C@@H](C[C@@H](/C=C/C3=C(N=C(N=C3C4=CC=C(C=C4)F)N(S(=O)(C)=O)C)C(C)C)O)O)=O.[Ca+2]
Synonyms :
Rosuvastatin hemicalcium; ZD 4522 Calcium; ZD 4522
MDL No. :MFCD04112702

Safety of Rosuvastatin Calcium

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H372-H410
Precautionary Statements:P273-P301+P312+P330-P314
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
THP-1 monocytes 10 μM 1 hour To investigate the effect of rosuvastatin on TNF-α-induced monocyte-endothelial cell adhesion. Results showed that rosuvastatin significantly inhibited TNF-α-induced adhesion of THP1 cells to HUVECs. PMC7156392
Human umbilical vein endothelial cells (HUVECs) 10 μM 1 hour To investigate the effect of rosuvastatin on TNF-α-induced monocyte-endothelial cell adhesion. Results showed that rosuvastatin significantly inhibited TNF-α-induced adhesion of THP1 cells to HUVECs and reduced the expression of ICAM and VCAM. PMC7156392
H9c2 cardiomyoblasts 20 µM 2 hours pretreatment followed by 12 hours stimulation Rosuvastatin inhibited TNF-α plus hypoxia-induced NLRP3 inflammasome activation and pyroptosis, as indicated by increased cell viability, decreased LDH release, and reduced PI uptake. PMC7804109
RAW 264.7 macrophages 10 and 20 μM 24 hours To study the effect of Rosuvastatin on LPS-induced inflammatory response in RAW 264.7 macrophages in vitro. Results showed that Rosuvastatin significantly inhibited LPS-induced production of TNF-α and IL-6, and suppressed NF-κB activation. PMC11236309
RAW264.7 macrophages 5, 10, 25 µM 24 hours To evaluate the effect of rosuvastatin on ox-LDL-induced foam cell formation. Results showed that rosuvastatin significantly reduced lipid droplets deposition in RAW264.7 cells and attenuated foam cell formation. PMC7877030
Human coronary artery smooth muscle cells (HCASMCs) 10 μM 24 hours To investigate the effect of rosuvastatin on TNF-α-induced migration and proliferation of smooth muscle cells. Results showed that rosuvastatin significantly inhibited TNF-α-induced migration and proliferation of HCASMCs and reduced the expression of Cyclin D1, Cyclin A2, PCNA, and c-Myc. PMC7156392
Human coronary artery endothelial cells (HCAECs) 0, 1, 2, 3 mg/ml 24, 48, 72 hours Rosuvastatin decreased apoptosis of HCAECs induced by CoCl2 by increasing anti-apoptosis Bcl-xl and Bcl-2 expression, and decreasing pro-apoptosis Bax, Bad, caspase-3 and caspase-9 expression. PMC7411340
Rat nucleus pulposus cells 20 μM 72 hours Rosuvastatin promotes matrix anabolism and suppresses catabolism in response to TNF-α stimulation. PMC10281883
Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) 0.3, 3, 30 µM approximately 4 minutes To evaluate the effect of rosuvastatin on cardiac action potential. Results showed that rosuvastatin significantly increased the maximum upstroke velocity (dV/dtmax) at 3 µM and 30 µM, and decreased the action potential duration (APD50) at 30 µM. PMC10199059

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
ApoE−/− mice High-fat diet-induced atherosclerosis model Oral 0.005% w/v Once daily for 13 weeks To investigate the preventive effect of rosuvastatin on periodontitis-induced atherosclerosis. Results showed that rosuvastatin significantly inhibited the development of periodontitis-induced atherosclerosis, reducing lipid deposition and atherogenic gene expression in the arterial wall and aortic sinus. PMC7156392
Adult male Wistar rats Acute model of hypertension Intravenous injection 0.5, 1, and 2 mg/kg 10 minutes apart, for 30 minutes Rosuvastatin enhanced the antihypertensive effect of cilostazol through effects on peripheral resistance, BRS, sympathovagal balance, endothelial dysfunction, and electrolytes balance. PMC10933198
Kunming mice Intracerebral hemorrhage model Tail intravenous injection 1 mg/kg Starting at 6 hours post-surgery, once daily for 7 days To evaluate the therapeutic effects of nanomicelles in ICH mice, results showed that nanomicelles significantly reduced neuron degeneration, inhibited inflammatory cell infiltration, reduced brain edema, and improved neurological deficits. PMC8068519
SD rats Myocardial infarction model Not specified 1 mg/kg Once daily for 60 days Rosuvastatin treatment decreased mitochondrial reactive oxygen species, inflammation, mitochondrial damage, lipid catabolism, heart failure and myocardial infarction areas, while improving cardiac function indicators, right and left ventricular ejection fraction, and increasing expression levels of JAK and STAT3 in myocardial tissue. PMC7411340
Male Sprague-Dawley rats Adriamycin-induced myocardial injury model Gavage 1 mg/kg/day Once daily for 6 weeks To investigate the protective effects of rosuvastatin on adriamycin-induced myocardial injury. Results showed that rosuvastatin significantly reduced the levels of HMGB1 and RAGE in the myocardium and alleviated the inflammatory response. PMC6202077
ApoE−/− mice High-fat diet-induced atherosclerosis model Oral gavage 10 mg/kg/day Once daily for 20 weeks To evaluate the effect of rosuvastatin on atherosclerotic plaque burden. Results showed that rosuvastatin significantly reduced plaque areas in the aorta inner surface and the aortic sinus, improved lipid profiles, and reduced contents of inflammatory cytokines in the circulation. PMC7877030
Sprague-Dawley rats Intervertebral disc degeneration model Intraperitoneal injection 10 mg/kg/day Once daily for 4 weeks Rosuvastatin inhibits IDD progression by alleviating pyroptosis and senescence and downregulating HMGB1 and p65. PMC10281883
Sprague Dawley rats Azithromycin-induced cardiotoxicity model Intragastric tube administration 2 mg/kg/day Once daily for two weeks To evaluate the protective effect of Rosuvastatin against Azithromycin-induced cardiotoxicity. Results showed that Rosuvastatin significantly ameliorated ECG changes, biochemical and oxidative stress markers alterations, and restored the arrangement of cardiac muscle fibers. PMC7816566
Mice Paclitaxel-induced neuropathic pain model Intraperitoneal injection 3, 10, 30, 100 mg/kg Once daily for 7 consecutive days Rosuvastatin dose-dependently reduced mechanical allodynia and thermal hyperalgesia in paclitaxel-treated mice, showing a superadditive interaction when combined with duloxetine PMC10179025
Mice Paclitaxel-induced neuropathic pain model Intraperitoneal injection 3, 10, 30, 100 mg/kg Once daily for 7 consecutive days Rosuvastatin dose-dependently decreased mechanical allodynia and thermal hyperalgesia in paclitaxel-treated mice PMC10179025
C57BL/6 mice Coronary microembolization (CME) model Oral 40 mg/kg/day Once daily for three days before and three days after Rosuvastatin improved CME-induced cardiac contractile dysfunction, reduced myocardial fibrosis and microinfarct size, decreased serum LDH levels, and inhibited NLRP3 inflammasome activation and pyroptosis. PMC7804109
C57BL/6 mice LPS-induced sepsis model Oral gavage 5 mg/kg/day Once daily for 20 weeks To investigate the protective effect of Rosuvastatin on LPS-induced sepsis in mice. Results showed that Rosuvastatin significantly reduced mortality, inhibited the production of inflammatory cytokines, and improved lung, liver, and kidney function. PMC11236309
Female Wistar rats High salt and cholesterol diet (HSCD)-induced cognitive impairment model Oral 5, 10, 15 mg/kg Once daily for 7 weeks To evaluate the effect of rosuvastatin in ameliorating HSCD-induced cognitive impairment via the Nrf2-ARE pathway. Results showed that rosuvastatin significantly reversed HSCD-induced changes in oxidative biomarkers, improved performance in neurobehavioral tests, and increased nuclear translocation of Nrf2. PMC6748700

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01241903 Acute Coronary Syndrome ... More >> Angioplasty, Transluminal, Percutaneous Coronary Hydroxymethylglutaryl-CoA Reductase Inhibitors Blood Platelets Less << Phase 1 Completed - United States, Kentucky ... More >> University of Kentucky Dept of Cardiology Lexington, Kentucky, United States, 40536 Less <<
NCT01241903 - Completed - -
NCT00747149 Type 2 Diabetes Phase 4 Completed - -
NCT00747149 - Completed - -
NCT03192579 Coronary Artery Disease Progre... More >>ssion Less << Phase 4 Completed - -
NCT02289430 Healthy Phase 1 Completed - -
NCT02737319 Nephropathy Phase 4 Completed - Brazil ... More >> Instituto Dante Pazzanese de Cardiologia São Paulo, Brazil, 04012-909 Less <<
NCT02502110 Paroxysmal Atrial Fibrillation Phase 4 Not yet recruiting June 2019 -
NCT01068626 Abdominal Obesity Phase 3 Completed - Sweden ... More >> Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothernburg Gothenburg, Sweden, 413 45 Less <<
NCT01068626 - Completed - -
NCT01526317 Pharmacokinetics and Drug Inte... More >>raction of Crestor and Glucodown SR Less << Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital, Yonsei University Seoul, Korea, Republic of, 120-752 Less <<
NCT02305862 Arteriosclerosis ... More >> Diabetes Mellitus Lipid Disorder Less << Not Applicable Unknown July 2017 China ... More >> Beijing Tiantan Hospital, Capital Medical University Recruiting Beijing, China, 100050 Contact: Qiang Fu, Dr    861067096562    fuqiang66882000@hotmail.com    Principal Investigator: Buxing Chen, Dr Less <<
NCT02962323 Healthy Subjects Phase 1 Completed - -
NCT01992211 Healthy Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02962310 Healthy Subjects Phase 1 Completed - -
NCT02283515 Chronic Periodontitis Phase 2 Phase 3 Completed - -
NCT02047175 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> The catholic university of Korea, seoul ST.Mary's hospital Seoul, Gangnam-gu, Korea, Republic of Less <<
NCT01524653 Venous Thromboembolism ... More >> Deep Vein Thrombosis Neoplasms Less << Phase 2 Completed - United States, Vermont ... More >> Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Less <<
NCT03037372 HIV Infection Phase 3 Not yet recruiting December 31, 2022 -
NCT01364220 Stroke Phase 3 Terminated(Slow enrollment) - Korea, Republic of ... More >> Department of Neurology, Hallym University Sacred Heart Hospital Anyang, Korea, Republic of Department of Neurology Colleage of Medicine Dong-A University Busan, Korea, Republic of Department of Neurology Pusan National University Hospital Busan, Korea, Republic of Department of Neurology, College of Medicine Inje University, Paik Hospital Busan, Korea, Republic of Department of Neurology, Fatima hospital Changwon, Korea, Republic of Department of Neurology, Samsung Changwon hospital Changwon, Korea, Republic of Department of Neurology, Dongsan Medical Center, Keimyung University School of Medicine Daegu, Korea, Republic of Department of Neurology, Yeungnam University School of Medicine Daegu, Korea, Republic of Department of Neurology Konyang University Hospital Daejon, Korea, Republic of Department of Neurology, Chonnam National University Hospital GwangJu, Korea, Republic of Department of Neurology, Chosun University Hospital Gwangju, Korea, Republic of Department of Neurology, Inha University Hospital Incheon, Korea, Republic of Department of Neurology, National health insurance corporation ilsan Hospital Koyang-shi, Korea, Republic of Department of Neurology, Severance Hospital Seoul, Korea, Republic of, 120-752 Department of Neurology Gangnam Severance Hospital Seoul, Korea, Republic of Department of Neurology Kyung Hee University East-West Neo Medical Center Seoul, Korea, Republic of Department of Neurology Seoul National University Hospital Seoul, Korea, Republic of Department of Neurology St. Mary's Hospital, Catholic University Seoul, Korea, Republic of Department of Neurology, Ewha Womans University Hospital Seoul, Korea, Republic of Department of Neurology, Hallym University Medical Center Seoul, Korea, Republic of Department of Neurology, Korean University Guro hospital Seoul, Korea, Republic of Department of Neurology, Kyung Hee University, College of Medicine Seoul, Korea, Republic of Department of Neurology, National Medical Center Seoul, Korea, Republic of Department of Neurology, Samsung Medical Center Seoul, Korea, Republic of Department of Neurology, University of Ulsan,Asan Medical Center Seoul, Korea, Republic of Department of Neurology,Sanggye Paik Hospital, Inje University College of Medicine Seoul, Korea, Republic of Department of Neurology, Wonju Christian Hospital Wonju, Korea, Republic of Less <<
NCT02030054 Coronary Artery Disease Phase 4 Unknown September 2015 Italy ... More >> Sapienza Univeristy of Rome Not yet recruiting Rome, Italy, 00166 Contact: MD MARINA POLACCO, medicine    +393333347960    dott.mpolacco@gmail.com    Principal Investigator: MD Marina Polacco, medicine Less <<
NCT00885872 Hyperlipidemia ... More >> Atherosclerosis Less << Phase 4 Unknown March 2012 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100000 Contact: Du Ruixue, Dr.    13693578338    drx1972@hotmail.com Less <<
NCT03044873 Autoimmune Diseases ... More >> Inflammatory Diseases Less << Phase 1 Completed - United States, Texas ... More >> PPD Phase I Clinic Austin, Texas, United States, 78744 Less <<
NCT02420899 Acute Coronary Syndrome Not Applicable Unknown July 2016 China, Beijing ... More >> Liu Qingbo Recruiting Beijing, Beijing, China, 100050 Contact: Qingbo Liu, master    13552328830    1035105896@qq.com Less <<
NCT02483871 Breast Cancer Phase 1 Withdrawn(Enrollment did not m... More >>eet anticipated goals. Eligibility was a challenge.) Less << - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT03156842 Essential Hypertension ... More >> Dyslipidemia Less << Phase 3 Recruiting May 1, 2019 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Less <<
NCT02125227 Healthy Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju-si, Jeollabuk-do, Korea, Republic of, 561712 Less <<
NCT01218802 HIV Infections ... More >> Heart Disease Less << Phase 2 Completed - United States, Ohio ... More >> University Hospitals of Cleveland Case Medical Center Cleveland, Ohio, United States, 44106 Less <<
NCT02484027 Infarction, Anterior Cerebral ... More >>Artery Less << Phase 4 Unknown September 2018 China, Jiangsu ... More >> Department of Neurology, Second Affiliated Hospital of Soochow University Not yet recruiting Suzhou, Jiangsu, China, 215004 Contact: Chun-Feng Liu, Ph.D, M.D.    00 86 512 67783307    liucf@suda.edu.cn    Principal Investigator: Yong-Jun Cao, Ph.D, M.D.          Principal Investigator: Wan-Qing Zhai, M.D          Sub-Investigator: Xia Zhang, M.D. Less <<
NCT03217409 Diabetes Mellitus and Hypercho... More >>lesterolemia Less << Phase 4 Recruiting July 2018 Korea, Republic of ... More >> Soon Chun Hyang University Hospital Cheonan Recruiting Cheonan, Korea, Republic of Soon Chun Hyang University Hospital Gumi Recruiting Gumi, Korea, Republic of Soon Chun Hyang University Hospital Bucheon Recruiting Gyeonggi-do, Korea, Republic of Soon Chun Hyang University Hospital Seoul Recruiting Seoul, Korea, Republic of Less <<
NCT00653588 Hypercholesterolemia ... More >> Coronary Heart Disease Less << Phase 3 Completed - -
NCT01218802 - Completed - -
NCT00228514 Rosuvastatin ... More >>Heart Failure Positron Emission Tomography (PET) Less << Phase 3 Completed - Netherlands ... More >> Research Site Groningen, Netherlands Less <<
NCT02859480 Coronary Artery Disease ... More >> Coronary Disease Cardiovascular Diseases Less << Phase 4 Recruiting December 2019 Korea, Republic of ... More >> Korea University Anam Hospital Recruiting Seoul, Korea, Republic of, 02841 Contact: Hyung Joon Joo, MD, PhD    +8229205445    drjoohj@gmail.com Less <<
NCT00653445 Hypercholesterolemia ... More >> Coronary Heart Disease Atherosclerosis Less << Phase 3 Completed - -
NCT03116516 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Recruiting December 2017 Korea, Republic of ... More >> Chonbuk National University Hospital Recruiting Jeonju, Korea, Republic of, 561-712 Contact: Mingul Kim, MD Less <<
NCT00680017 Dyslipidemia ... More >>Kidney Disease Less << Phase 3 Completed - -
NCT02314286 Severe Pre-eclampsia Phase 1 Phase 2 Unknown July 2016 -
NCT00680017 - Completed - -
NCT01982461 Hypercholesterolemia Not Applicable Unknown - Taiwan ... More >> Tri-Service General Hospital Recruiting Taipei, Taiwan, 11490 Contact    886-2-87923311 ext 10552    tsghirb@ndmctsgh.edu.tw Less <<
NCT01874743 HIV-1 Infection Phase 2 Unknown September 2013 France ... More >> St Antoine Hospital Recruiting Paris, France, 75012 Contact: pauline Campa, MD    49283044 ext +331    pauline.campa@sat.aphp.fr    Principal Investigator: Pierre-Marie Girard, PHD,MD          HEGP Recruiting Paris, France, 75015 Contact: Laurence Weiss, PHD,MD    56093299 ext +331    laurence.weiss@egp.aphp.fr    Principal Investigator: Laurence Weiss, PHD,MD Less <<
NCT00344123 HIV Infections Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287 Less <<
NCT02341794 Intracranial Arterial Diseases Not Applicable Unknown July 2018 Japan ... More >> Tokyo Medical University Recruiting Shinjuku-ku, Tokyo, Japan, 160-8402 Principal Investigator: Daisuke Nishi, M.D., Ph.D. Less <<
NCT02317016 Non Small Cell Lung Cancer Phase 1 Completed - United States, Virginia ... More >> Research Site Fairfax, Virginia, United States, 22031 France Research Site Bordeaux Cedex, France, 33075 Research Site Bordeaux Cedex, France, 33076 Research Site Montpellier, France, 34298 Research Site Rennes, France, 35033 Spain Research Site Barcelona, Spain, 08036 Research Site Madrid, Spain, 28007 Research Site Málaga, Spain, 29010 Research Site Sevilla, Spain, 41013 Research Site Sevilla, Spain, 41071 United Kingdom Research Site London, United Kingdom, EC1A 7BE Research Site London, United Kingdom, W1G 6AD Research Site Manchester, United Kingdom, M20 4BX Less <<
NCT01469416 Healthy Phase 1 Completed - United States, California ... More >> Clinical Research Center, UCSF San Francisco, California, United States, 94143 Less <<
NCT02317016 - Completed - -
NCT02772640 Hypercholesterolemia Phase 4 Unknown December 2016 Poland ... More >> Cardiology Department, Dr. A. Jurasz University Hospital Recruiting Bydgoszcz, Kujawsko-Pomorskie, Poland, 85-094 Contact: Karolina Obońska, MD, PhD    +48 52 5854023    kalaobonska@op.pl Less <<
NCT02387619 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Yonsei University Health System Seoul, Seodaemun-gu, Korea, Republic of, 120-752 Less <<
NCT02029625 Dyslipidemia Phase 1 Completed - Korea, Republic of ... More >> Kyungpook National Hospital Jung-gu, Daegu, Korea, Republic of, 700-721 Less <<
NCT00815659 Metabolic Syndrome Phase 4 Completed - Turkey ... More >> Research site Ankara, Besevler, Turkey Research site Kayseri, Erciyes, Turkey Research site Istanbul, Haseki, Turkey Research site Kocaeli, Umuttepe, Turkey Research Site Izmir, Turkey Research Site Trabzon, Turkey Less <<
NCT01929512 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT02574845 Healthy Phase 1 Completed - Germany ... More >> Boehringer Ingelheim Investigational Site Biberach, Germany Less <<
NCT00815659 - Completed - -
NCT02951962 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Chunju, Korea, Republic of, 561-712 Less <<
NCT00240318 Coronary Arteriosclerosis Phase 3 Completed - -
NCT02574845 - Completed - -
NCT02546323 Atherosclerosis Phase 3 Active, not recruiting January 31, 2019 China ... More >> Research Site Beijing, China, 100035 Research Site Beijing, China, 100050 Research Site Beijing, China, 100191 Research Site Beijing, China, 100853 Research Site Bengbu, China, 233060 Research Site Changsha, China, 410011 Research Site Chongqin, China, 400042 Research Site Guangzhou, China, 510080 Research Site Guangzhou, China, 510120 Research Site Guangzhou, China, 510260 Research Site Guangzhou, China, 510515 Research Site Guangzhou, China, 510630 Research Site Haerbin, China, 150001 Research Site Nanchang, China, 330006 Research Site Nanjing, China, 210009 Research Site Ningbo, China, 315010 Research Site Shanghai, China, 200032 Research Site Shanghai, China, 200065 Research Site Shanghai, China, 200090 Research Site Shenyang, China, 110001 Research Site Tianjin, China, 300457 Research Site Wenzhou, China, CN-325000 Research Site Wuhan, China, 430022 Research Site Xian, China, 710061 Less <<
NCT02418884 Coronary Artery Disease Phase 4 Unknown March 2018 -
NCT00885495 HIV Infections Phase 1 Phase 2 Unknown August 2009 United States, Ohio ... More >> University of Cincinnati AIDS Clinical Trials Unit Cincinnati, Ohio, United States, 45267 Less <<
NCT00225589 Hypercholesteremia Phase 3 Completed - -
NCT03026933 Dyslipidemias Phase 3 Completed - -
NCT01918709 Hypertension, Hyperlipidemia Phase 1 Completed - Korea, Republic of ... More >> Clinical Trial Center, Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT00984932 Systemic Sclerosis Phase 3 Completed - Egypt ... More >> Faculty of Medicine, University of Alexandria Alexandria, Egypt, 203 Less <<
NCT03677297 Adult Periodontitis Phase 4 Completed - India ... More >> Sukhada Deo Pune, Maharashtra, India, 411018 Less <<
NCT00966472 Squamous Cell Carcinoma ... More >> Non-Small Cell Lung Cancer Less << Phase 1 Completed - Canada, Ontario ... More >> The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT02299245 Telomere Shortening ... More >> Telomere Length, Mean Leukocyte 22q Telomere Deletion Syndrome Less << Phase 4 Unknown November 2016 -
NCT02185963 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of Less <<
NCT02532309 Carotid Atherosclerosis Phase 4 Unknown - China, Beijing ... More >> China-Japan Friendship Hospital Recruiting Beijing, Beijing, China Contact: Liu Wei, Ph.D       63483495@qq.com    Contact: Jiao Jinsong, Professor       jiaojinsong@aliyun.com    Principal Investigator: Liu Wei, Ph.D Less <<
NCT02011633 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT02077257 Acute Coronary Syndrome Phase 4 Unknown May 2016 China, Beijing ... More >> Beijing Anzhen Hospital Recruiting Beijing, Beijing, China Contact: Changsheng Ma, PhD Less <<
NCT02364258 Dyslipidemia Phase 1 Recruiting December 2017 United States, Missouri ... More >> Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 Contact: Jon Wagner, DO    816-234-3000 ext 59373    jbwagner@cmh.edu    Principal Investigator: Jon B Wagner, DO Less <<
NCT03019549 Healthy Phase 1 Completed - United States, Florida ... More >> Covance Clinical Research Inc Daytona Beach, Florida, United States, 32117 Less <<
NCT00660764 - Completed - -
NCT01975194 Stroke Transi... More >>ent Ischemic Attack Less << Phase 4 Terminated(loss of research pe... More >>rsonnel) Less << - United States, Michigan ... More >> Detroit Medical Center Detroit, Michigan, United States, 48201 Less <<
NCT02104843 Hepatitis C Phase 1 Completed - -
NCT01775579 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Samgsung Seoul Hospital Seoul, Korea, Republic of Less <<
NCT03699774 Drug Pharmacokinetics in Healt... More >>hy Volunteers Less << Phase 1 Completed - United States, Texas ... More >> Worldwide Clinical Trials (WCT) Early Phase Services San Antonio, Texas, United States, 78217 Less <<
NCT01899027 Arterial Hypertension Phase 4 Unknown December 2017 Italy ... More >> University Sapienza Not yet recruiting Rome, Italy, 00161 Contact: Cesare Greco, MD    +390649971 ext 123    cesare.greco@uniroma1.it    Contact: Francesco Pelliccia, MD    +390649971 ext 123    f.pelliccia@mclink.it    Principal Investigator: Francesco Pelliccia, MD Less <<
NCT00986999 HIV Infections ... More >> Cardiovascular Disease Less << Phase 2 Phase 3 Terminated(poor enrollment) - United States, Hawaii ... More >> Hawaii Center for AIDS Honolulu, Hawaii, United States, 96813 Less <<
NCT01299038 Breast Cancer Phase 2 Active, not recruiting December 2018 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT02101125 Immunosuppression For Disease Phase 1 Completed - United States, Texas ... More >> Healthcare Discoveries, Llc D/B/A Icon Development Solutions San Antonio, Texas, United States, 78209 Less <<
NCT01389388 Carotid Artery Plaque ... More >> Ankylosing Spondylitis Rheumatoid Arthritis Less << Not Applicable Completed - Norway ... More >> Anne Grete Semb, Department of Rheumatology, Diakonhjemmet hospital Oslo, Norway, NO-0319 Less <<
NCT00986999 - Terminated(poor enrollment) - -
NCT01382277 Hyperlipidemia ... More >> Coronary Artery Disease Less << Phase 4 Unknown April 2013 China, Beijing ... More >> Peking University First Hospital Recruiting Beijing, Beijing, China, 100034 Contact: Yanjun Gong, MD    86-10-83572299    gongyanjun111@163.com    China Division of Cardiology, Peking University First Hospital Recruiting Beijing, China, 100034 Contact: Jie Jiang, MD    86-10-66551383 Less <<
NCT01968577 Coronary Artery Disease Phase 4 Unknown December 2013 Brazil ... More >> Instituto Dante Pazzanese de Cardiologia Recruiting Sao Paulo, Brazil, 04012-180 Contact: AMANDA S GUERRA, DIRECTOR    55-11-5085-6000    diretoriageral@dantepazzanese.org.br    Principal Investigator: KLEBER B A MARTINS, MD Less <<
NCT02026817 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT03359291 Healthy Subjects Phase 1 Completed - Germany ... More >> CRS Clinical Research Services Mannheim Mannheim, Germany, 68167 Less <<
NCT02593487 Hyperlipemia ... More >>Coronary Heart Disease Less << Phase 4 Unknown June 2017 China, Chongqing ... More >> Xu-kai Wang Not yet recruiting Chongqing, Chongqing, China, 400042 Contact: Qing-kai Yan, MD    +8618623457875    yanqingkai@hotmail.com    Contact: Peng Cai, MD    +8602368757810    doubleboy1987@sina.com Less <<
NCT01613729 Dyslipidemia Phase 4 Unknown December 2013 Bangladesh ... More >> BSMMU Dhaka, Bangladesh, 1000 Less <<
NCT03169985 Coronary Artery Disease Phase 4 Recruiting December 31, 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: Joo-Yong Hahn, MD, PhD    82-2-3410-6653    ichjy1@gmail.com    Contact: Joo Myung Lee, MD, MPH    82-2-3410-1246    drone80@hanmail.net Less <<
NCT02594800 Atherosclerosis Phase 4 Unknown March 28, 2018 China, Zhejiang ... More >> The second affiliated hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Min Lou, Ph.D    13958007213    z2loumin@163.com Less <<
NCT02083627 Drug-Drug Interaction (DDI) ... More >> Intestinal Absorption Healthy Subjects Pharmacokinetics of Rosuvastatin Pharmacokinetics of Fidaxomicin Less << Phase 1 Completed - Germany ... More >> Parexel GmbH Berlin, Germany, D-14059 Less <<
NCT03007524 Acute Coronary Syndrome Phase 4 Recruiting December 2019 China, Jiangsu ... More >> Nanjing First Hospital, Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210006 Contact: Zhang Yao-Jun, MD          Contact: Zhu Yong-Xiang, MSC Less <<
NCT01751074 Atherosclerosis Phase 1 Completed - United States, California ... More >> GSK Investigational Site Glendale, California, United States, 91206 Less <<
NCT00463606 Hypercholesterolemia ... More >> Dyslipidemia Less << Phase 3 Completed - -
NCT00463606 - Completed - -
NCT01490398 Hypertension ... More >>Cardiovascular Risk Factors Less << Phase 4 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT03175835 Dyslipidemias Phase 1 Completed - Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of Less <<
NCT02284503 Non-ST-elevation Acute Coronar... More >>y Syndromes Less << Phase 4 Unknown June 2016 China, Shanghai ... More >> Zhongshan Hospital Fudan University Not yet recruiting Shanghai, Shanghai, China, 200032 Contact: Yinman Wang, Master    +86 21 64041990 ext 2521    wang.yinman@zs-hospital.sh.cn    Principal Investigator: Junbo Ge, MD Less <<
NCT00766025 CYP2C19 Poor|Extensive Metabol... More >>izers Less << PHASE1 COMPLETED 2025-02-09 Research Site, Taipei, Taiwan
NCT02106767 Healthy Phase 1 Unknown March 2016 United States, California ... More >> CTSI Clinical Research Center, UCSF San Francisco, California, United States, 94143 Less <<
NCT02705547 Friedreich Ataxia Early Phase 1 Completed - United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT01863914 End-stage Kidney Disease ... More >> Diabetes Mellitus Arteriovenous Fistula Less << Phase 2 Recruiting December 2018 Taiwan ... More >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Chen-Fuh Lam, MD, PhD    8866-2353535 ext 5348    lamcf@mail.ncku.edu.tw    Principal Investigator: Chen-Fuh Lam, MD, PhD          Sub-Investigator: Jun-Neng Roan, MD Less <<
NCT02215174 Statin Pharmacokinetics Pre an... More >>d Post Gastric Bypass Surgery Less << Phase 1 Unknown - United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Hsin-Fang Wu, PhD candidate    415-476-5890    hf.wu@ucsf.edu    Contact: Leslie Benet, PhD    415-476-5890    leslie.benet@ucsf.edu    Principal Investigator: Leslie Benet, PhD          Taiwan E-Da Hospital Not yet recruiting Kaohsiung, Taiwan, 82445 Contact: Cheng-Fang Chiu, Master    +886912370601    ed105456@edah.org.tw    Contact: Chih-Kun Huang, M.D    +886-7-6150011 ext 3036    dr.ckhuang@hotmail.com    Sub-Investigator: Chih-Kun Huang, M.D Less <<
NCT01218347 Organic Anion Transporting Pol... More >>ypeptide1B1 (OATP1B1) Rosuvastatin Less << Phase 4 Completed - Korea, Republic of ... More >> Clinical Trials Center, Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT01524601 Disorder Related to Renal Tran... More >>splantation Hypercholesterolemia Less << Phase 4 Completed - Norway ... More >> Oslo University Hospital, Rikshospitalet Oslo, Norway, 0027 Less <<
NCT03715101 Elderly Phase 1 Completed - -
NCT01466608 Hypercholesterolemia Phase 4 Completed - Korea, Republic of ... More >> Clinical Trials Center, Seoul National University Hospital Seoul, Korea, Republic of, 110-799 Less <<
NCT02569645 Rectal Cancer Phase 2 Recruiting May 2021 Canada, Alberta ... More >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Less <<
NCT03216304 Healthy Phase 1 Completed - Switzerland ... More >> CROSS Research SA, Phase I Unit Arzo, Ticino, Switzerland, 6864 Less <<
NCT00554138 Adenosine Metabolism Not Applicable Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB Less <<
NCT01923077 Acute Myocardial Infarction Phase 2 Unknown September 2013 Denmark ... More >> OUH/Svendborg Hospital Svendborg, Funen, Denmark, 5700 Less <<
NCT02800902 Chronic Periodontitis Phase 2 Phase 3 Completed - India ... More >> Government Dental College and Research Institute Bangalore, Karnataka, India, 560002 Less <<
NCT00114491 - Completed - Portugal ... More >> Hospital Pedro Hispano Porto, Portugal Less <<
NCT01964365 Healthy Phase 1 Completed - Korea, Republic of ... More >> Inje University College of Medicine Busan Paik Hospital Busan, Korea, Republic of Less <<
NCT00695539 - Completed - Greece ... More >> Research Site Alexandroupoli, Greece Research Site Athens, Greece Research Site Iraklio, Crete, Greece Research Site Larissa, Greece Research Site Rio, Patra, Greece Research Site Thessaloniki, Greece Less <<
NCT03446261 Type 2 Diabetes Mellitus ... More >> Hypercholesterolemia Less << Phase 4 Not yet recruiting April 2019 Korea, Republic of ... More >> Asan Medical Center Not yet recruiting Seoul, Korea, Republic of Inje University Sanggye Paik Hospital Not yet recruiting Seoul, Korea, Republic of Kangbuk Samsung Hospital Not yet recruiting Seoul, Korea, Republic of Konkuk University Medical Center Not yet recruiting Seoul, Korea, Republic of Kyung Hee University Hospital at Gangdong Not yet recruiting Seoul, Korea, Republic of Less <<
NCT00487136 Healthy Phase 1 Completed - United States, Arkansas ... More >> Site Ref # / Investigator 5290 Little Rock, Arkansas, United States, 72205 Less <<
NCT00379249 Hypercholesterolemia Phase 3 Completed - -
NCT01609907 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Yuhan Corporation Seoul, Korea, Republic of Less <<
NCT03403556 Atherosclerotic Cardiovascular... More >> Disease Type 2 Diabetes Less << Phase 4 Not yet recruiting February 2019 Korea, Republic of ... More >> Daegu Catholic University Medical Center Not yet recruiting Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Not yet recruiting Daegu, Korea, Republic of Kyungpook National University Hospital Not yet recruiting Daegu, Korea, Republic of Yeungnam University Medical Center Not yet recruiting Daegu, Korea, Republic of The Catholic University of Korea, St. Vincent's Hospital Not yet recruiting Gyeonggi-do, Korea, Republic of Korea University Anam Hospital Not yet recruiting Seoul, Korea, Republic of Less <<
NCT00800800 Aortic Stenosis Phase 3 Completed - Canada, Alberta ... More >> Research site Calgary, Alberta, Canada Research site Edmonton, Alberta, Canada Canada, British Columbia Research site Surrey, British Columbia, Canada Research site Vancouver, British Columbia, Canada Research site Victoria, British Columbia, Canada Canada, Manitoba Research site Edmonton, Manitoba, Canada Canada, Ontario Research site Brampton, Ontario, Canada Research site Cambridge, Ontario, Canada Research site Kitchener, Ontario, Canada Research site Montreal, Ontario, Canada Research site Ottawa, Ontario, Canada Research site Toronto, Ontario, Canada Canada, Quebec Research site Montreal, Quebec, Canada Canada Research site Halifax, Canada Research site St. John's, Canada Less <<
NCT01425398 Valvular Cardiac Surgery Phase 3 Unknown November 2013 Canada, Quebec ... More >> Royal Victoria Hospital Not yet recruiting Montreal, Quebec, Canada, H3A 1A1 Contact: Jennifer Chung, M.D.    438-886-3901    jennifer.chung2@mail.mcgill.ca    Principal Investigator: Jennifer Chung, M.D.          Principal Investigator: Benoit De Varennes, M.D.          Principal Investigator: Jacques Genest, M.D.          Sub-Investigator: Peter Goldberg, M.D. Less <<
NCT01831479 Healthy Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT03494270 ASCVD Phase 4 Recruiting December 2019 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of Contact: In-ho Chae    82-31-787-7012    ihchae@snu.ac.kr Less <<
NCT02675309 Healthy Phase 1 Completed - United Kingdom ... More >> Investigational center City name, United Kingdom Less <<
NCT00653965 Hypercholesterolemia ... More >> Dyslipidaemia Less << Phase 3 Completed - -
NCT02645227 Chronic Periodontitis Phase 2 Phase 3 Completed - India ... More >> Government Dental College and Research Institute Bangalore, Karnataka, India, 560002 Less <<
NCT00315510 Ischemia Phase 2 Completed - Netherlands ... More >> Clinical Research Centre Nijmegen; Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT00176332 Heart Failure Phase 2 Completed - Germany ... More >> University of Leipzig, Heart Center, Department of Internal Medicine / Cardiology Leipzig, Saxony, Germany, 04289 Less <<
NCT02082665 Cancer Phase 1 Completed - United States, New Hampshire ... More >> GSK Investigational Site Lebanon, New Hampshire, United States, 03756 Spain GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Madrid, Spain, 28040 GSK Investigational Site Sevilla, Spain, 41013 Less <<
NCT02280590 Hyperlipidemia Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00951132 Depression Phase 2 Unknown December 2010 Norway ... More >> Akershus University Hospital Recruiting Lorenskog, Akershus, Norway, 1478 Contact: Gunnar Einvik, MD    41104542 ext +47    gunnar.einvik@medisin.uio.no Less <<
NCT00355615 - Completed - -
NCT03204058 Chronic Periodontitis Phase 2 Phase 3 Completed - -
NCT00355615 Familial Hypercholesterolemia Phase 3 Completed - United States, California ... More >> Research Site Los Angeles, California, United States United States, New York Research Site Hyde Park, New York, United States United States, Ohio Research Site Cincinnati, Ohio, United States United States, Pennsylvania Research Site Wexford, Pennsylvania, United States Canada, Ontario Research Site Hamilton, Ontario, Canada Research Site Toronto, Ontario, Canada Canada, Quebec Research Site Chicoutimi, Quebec, Canada Research Site Laval, Quebec, Canada Research Site Sherbrook, Quebec, Canada Netherlands Research SIte Amsterdam, Netherlands Research Site Eindhoven, Netherlands Research Site Groningen, Netherlands Research Site Hoorn, Netherlands Research Site Rotterdam, Netherlands Research Site Utrecht, Netherlands Research SIte Waalwijk, Netherlands Norway Research Site Oslo, Norway Spain Research Site Cordoba, Spain Research Site Madrid, Spain Research Site Reus, Spain Less <<
NCT00929734 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 2 Completed - Norway ... More >> Akershus University Hospital Lørenskog, Akershus, Norway, 1478 Less <<
NCT01526460 Platelet Dysfunction Phase 2 Completed - Italy ... More >> IRCCS San Raffaele Monte Tabor Milan, Italy, 20132 Less <<
NCT03597412 Atherosclerotic Cardiovascular... More >> Disease Type 2 Diabetes Mellitus Less << Phase 4 Not yet recruiting March 30, 2020 Korea, Republic of ... More >> Kangbuk Samsung Hospital Not yet recruiting Seoul, Korea, Republic of Less <<
NCT01414803 Hyperlipidemia Phase 4 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT02079506 Healthy Phase 1 Completed - Korea, Republic of ... More >> Chungnam National University Hospital Jung-gu, Daejeon, Korea, Republic of, 301-721 Less <<
NCT00929734 - Completed - -
NCT00851175 Atherosclerosis ... More >> Cardiovascular Disease Less << Phase 4 Completed - Netherlands ... More >> RUNMC Nijmegen, Netherlands, 6525 GA Less <<
NCT00631189 Type IIa and IIb Hypercholeste... More >>rolaemia Less << Phase 4 Completed - -
NCT00689416 Atherosclerosis ... More >> Inflammatory Activity in Carotid Arteries Less << Early Phase 1 Completed - Sweden ... More >> Research Site Uppsala, Sweden Less <<
NCT01164397 - Completed - Mexico ... More >> Research Site Mexico, DF, Mexico Research Site Guadalajara, Jalisco, Mexico Research Site Cuernavaca, Morelos, Mexico Research Site Monterrey, Nuevo Leon, Mexico Research Site Veracruz, Xalapa, Mexico Research Site Merida, Yucatan, Mexico Research Site Durango, Mexico Research Site Puebla, Mexico Research Site San Luis Potosi, Mexico Less <<
NCT00555230 Rheumatoid Arthritis Phase 2 Completed - China ... More >> School of Pharmacy CUHK Hong Kong, China Less <<
NCT01918358 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT02205190 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Kyungpook National University Hospital Daegu, Korea, Republic of, 700-721 Less <<
NCT00654394 Carotid Artery Stenosis ... More >> Hypercholesterolemia Less << Phase 3 Completed - -
NCT00585143 Dyslipidemia, Renal Insufficie... More >>ncy Less << Phase 1 Completed - United States, Florida ... More >> Site Reference ID/Investigator# 6610 Gainesville, Florida, United States, 32608 Site Reference ID/Investigator# 6738 Miami, Florida, United States, 33136 United States, Minnesota Site Reference ID/Investigator# 7723 Minneapolis, Minnesota, United States, 55404 United States, Tennessee Site Reference ID/Investigator# 7319 Knoxville, Tennessee, United States, 37920 United States, Texas Site Reference ID/Investigator# 6928 San Antonio, Texas, United States, 78209 United States, Virginia Site Reference ID/Investigator# 8280 Richmond, Virginia, United States, 23298-0160 Less <<
NCT01646307 Focus of Study Phase 4 Unknown June 2013 China ... More >> Beijing Anzhen Hospital Recruiting Beijing, China, 100029 Sub-Investigator: Ying-Xin Zhao, MD          Principal Investigator: Yu-Jie Zhou, MD, PhD Less <<
NCT00631189 - Completed - -
NCT00295373 Nonfamilial Hypercholesterolem... More >>ia Physical Inactivity Less << Phase 4 Unknown August 2007 United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47906 Less <<
NCT00688454 - Completed - -
NCT03187496 NASH Phase 1 Completed - United States, Kansas ... More >> Pharmaceutical Research Associates, Inc., Lenexa, Kansas, United States, 66219 Less <<
NCT02233218 Healthy Male Volunteer Phase 1 Completed - Korea, Republic of ... More >> Dong-A university hospital Pusan, Korea, Republic of Less <<
NCT01921946 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Kyungpook National University Hospital Daegu, Korea, Republic of, 700-721 Less <<
NCT00786136 Diabetes Mellitus ... More >> Chronic Kidney Disease Less << Phase 4 Completed - -
NCT01653119 Acute Coronary Syndrome ... More >> Diabetes Mellitus Less << Not Applicable Unknown December 2015 China, Beijing ... More >> Peking University Third Hospital Recruiting Beijing, Beijing, China, 100191 Contact: Wei Gao, Master    +8613901366179    dr_gaowei@medmail.com.cn    Contact: Wei Zhao, Doctor    +8618600017812    beate_vv@bjmu.edu.cn Less <<
NCT02397538 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Inje University Busan Paik Hospital Busan, Korea, Republic of, Korea, Republic of Less <<
NCT01863225 Dyslipidemia ... More >>Coronary Artery Disease Less << Phase 2 Terminated - Australia, South Australia ... More >> Royal Adelaide Hospital / CMAX Adelaide, South Australia, Australia, 5000 Less <<
NCT02166814 Essential Hypertension, Dyslip... More >>idemia Less << Phase 3 Completed - Korea, Republic of ... More >> Seoul university Bundang hospital Bundang, Korea, Republic of Dong-A university hospital Busan, Korea, Republic of Inje Heaundai Paik hospital Busan, Korea, Republic of Inje university Busan Paik hospital Busan, Korea, Republic of ChungNam university hospital ChungNam, Korea, Republic of DanGuk university hospital Chungnam, Korea, Republic of The Catholic university of Korea Daegu hospital Daegu, Korea, Republic of DongGuk university Gyeongju hospital Gyeongju, Korea, Republic of DongGuk university Ilsan hospital Ilsan, Korea, Republic of Inje university Ilsan Paik hospital Ilsan, Korea, Republic of Gachon university Gil medical center Incheon, Korea, Republic of Inha university hospital Incheon, Korea, Republic of Jeju national university hospital Jeju, Korea, Republic of JeonNam university hospital JeonNam, Korea, Republic of Kyungbook National university hospital Kyungbook, Korea, Republic of Gangnam Severance hospital Seoul, Korea, Republic of Jeil hospital Seoul, Korea, Republic of Korea university Anam hospital Seoul, Korea, Republic of Korea university Guro hospital Seoul, Korea, Republic of Kyunghee university hospital Seoul, Korea, Republic of Samsung Seoul hospital Seoul, Korea, Republic of Seoul national university hospital Seoul, Korea, Republic of Severance hospital Seoul, Korea, Republic of The Catholic university St. Mary hospital Seoul, Korea, Republic of Aju university hospital Suwon, Korea, Republic of YoungNam university hospital YoungNam, Korea, Republic of Less <<
NCT00654407 Hypercholesterolemia Phase 3 Completed - -
NCT01573143 Atrial Fibrillation ... More >> Myocardium; Injury Less << Phase 4 Completed - China, Beijing ... More >> Fuwai Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China, 100037 Less <<
NCT00651378 Hypercholesterolemia ... More >> Atherosclerosis Coronary Artery Disease Less << Phase 4 Terminated(Slow enrollment [HI... More >>GH SCREEN FAILURE RATE]) Less << - -
NCT03088254 Dyslipidemia With Hypertension Phase 3 Completed - Korea, Republic of ... More >> Chungnam National University Hospital Daejeon, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Seoul National University Bundang Hospital Gyeonggi-do, Korea, Republic of Gachon University Gil Medical Center Incheon, Korea, Republic of Inje University Haeundae Paik Hospital Pusan, Korea, Republic of Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of Kangbuk Samsung Hospital Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of KyungHee University Hospital at Gangdong Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of SoonChunHyang University Hospital, Seoul Seoul, Korea, Republic of The Catholic University of Korea Seoul St. Mary's Hospital Seoul, Korea, Republic of Less <<
NCT03074630 Diabetes Mellitus, Type 2 ... More >> Hypercholesterolemia Less << Phase 4 Completed - Netherlands ... More >> Academic Medical Center Amsterdam, North Holland, Netherlands, 1105AZ Less <<
NCT03753477 Healthy Phase 1 Completed - Korea, Republic of ... More >> Busan Paik Hospital Busan, Korea, Republic of Less <<
NCT01798602 H1N1 Influenza Phase 2 Terminated(H1N1 pandemic concl... More >>uded) Less << - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT00240331 Renal Failure Phase 3 Completed - -
NCT02608242 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Terminated(sponsor decision) - Korea, Republic of ... More >> Chonbuk National University Hospital Chunju, Korea, Republic of, 561-712 Less <<
NCT00240331 - Completed - -
NCT02300363 Healthy Phase 1 Completed - United States, Indiana ... More >> Lexicon Investigational Site Evansville, Indiana, United States, 47710 Less <<
NCT02106845 Neoplasms Phase 1 Active, not recruiting December 31, 2018 Germany ... More >> Freiburg, Baden-Württemberg, Germany, 79106 Frankfurt, Hessen, Germany, 60488 Herne, Nordrhein-Westfalen, Germany, 44625 Hungary Budapest, Hungary, 1083 Budapest, Hungary, 1122 Less <<
NCT02611518 Healthy Phase 1 Completed - Germany ... More >> Berlin, Germany Less <<
NCT00913562 Glaucoma Diab... More >>etes Less << Phase 4 Withdrawn - Austria ... More >> Department of Clinical Pharmacology, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01007279 Periprocedural Myocardial Necr... More >>osis Less << Phase 3 Completed - Italy ... More >> Policlinico Umberto I Rome, Italy, 00166 Less <<
NCT00505154 Dilated Cardiomyopathy Phase 3 Completed - Norway ... More >> Oslo University Hospital Oslo, Norway Less <<
NCT01929070 Healthy Phase 1 Completed - Korea, Republic of ... More >> Samsung medical center Seoul, Korea, Republic of Less <<
NCT01228227 Assess the Periprocedural Myoc... More >>ardial Necrosis Less << Phase 3 Completed - Italy ... More >> Policlinico Umberto I Roma, Italy Less <<
NCT01795937 Healthy Phase 1 Completed - Germany ... More >> 1220.61.1 Boehringer Ingelheim Investigational Site Ingelheim, Germany Less <<
NCT01795937 - Completed - -
NCT02369250 Furcation Defects Phase 4 Completed - -
NCT00473655 Hypertriglyceridemia ... More >> Hyperlipoproteinemia Type IV Hyperlipoproteinemia Type V Hyperlipoproteinemia Type IIb Hyperlipidemia Less << Phase 4 Completed - Mexico ... More >> Research Site Mexico City, DF, Mexico Research Site Guadalajara, Jalisco, Mexico Research Site Monterrey, Nuevo Leon, Mexico Less <<
NCT00329160 Hypercholesteremia Phase 4 Completed - Japan ... More >> Research Site Gifu, Japan Research Site Hamada, Japan Research Site Hiroshima, Japan Research Site Ichinomiya, Japan Research Site Inba-mura, Japan Research Site Izumisano, Japan Research Site Izumi, Japan Research Site Izumo, Japan Research Site Kagoshima, Japan Research Site Kanazawa, Japan Research Site Kasuga, Japan Research Site Kobe, Japan Research Site Komaki, Japan Research Site Konan-cho, Japan Research Site Kumamoto, Japan Research Site Kurume, Japan Research Site Kyoto, Japan Research Site Omiya, Japan Research Site Osaka, Japan Research Site Sapporo, Japan Research Site Shinjo, Japan Research Site Shunan, Japan Research Site Suita, Japan Research Site Tokyo, Japan Research Site Ube, Japan Research Site Yamaguchi, Japan Research Site Yokohama, Japan Less <<
NCT01058915 Acute Coronary Syndrome Not Applicable Completed - Denmark ... More >> Department of Cardiology, Odense University Hospital Odense, Fuenen, Denmark, 5000 Less <<
NCT00371579 Hepatitis C Not Applicable Withdrawn(no actual patients r... More >>ecruited within year 1 after ethical committee approval) Less << October 2007 Netherlands ... More >> University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Less <<
NCT00329160 - Completed - -
NCT00335699 Hypercholesterolemia Phase 4 Completed - Korea, Republic of ... More >> Research Site DaeGu, Korea, Republic of Research Site IkSan, Korea, Republic of Research Site JeonJu, Korea, Republic of Research Site JinJu, Korea, Republic of Research Site KwangJu, Korea, Republic of Research Site Pusan, Korea, Republic of Research Site Ulsan, Korea, Republic of Less <<
NCT02089061 Acute Coronary Syndromes Phase 1 Completed - -
NCT02626234 cMET-dysregulated Advanced Sol... More >>id Tumors Less << Phase 1 Completed - United States, Georgia ... More >> Emory University School of Medicine/Winship Cancer Institute Phase 1 Working Group Atlanta, Georgia, United States, 30322 United States, New Hampshire Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Austria Novartis Investigative Site Vienna, Austria, A-1090 Belgium Novartis Investigative Site Edegem, Belgium, 2650 Czechia Novartis Investigative Site Brno, Czechia, 65653 Greece Novartis Investigative Site Ioannina, GR, Greece, 455 00 Novartis Investigative Site Athens, Greece, 18547 Italy Novartis Investigative Site Milano, MI, Italy, 20141 Novartis Investigative Site Candiolo, TO, Italy, 10060 Novartis Investigative Site Bologna, Italy, 40138 Novartis Investigative Site Napoli, Italy, 80131 Spain Novartis Investigative Site Majadahonda, Madrid, Spain, 28222 Novartis Investigative Site Madrid, Spain, 28034 United Kingdom Novartis Investigative Site London, United Kingdom, W1G 6AD Novartis Investigative Site Manchester, United Kingdom, M20 9BX Less <<
NCT01936805 Atherosclerosis Phase 3 Completed - Turkey ... More >> Yuksek Ihtisas Hospital Ankara, Altindag, Turkey, 06100 Less <<
NCT01185938 Acute Coronary Syndrome Phase 4 Completed - Italy ... More >> Cardiology Division, Prato Hospital Prato, Italy, 59100 Less <<
NCT02127320 Healthy Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, Korea, Republic of Less <<
NCT01547377 Dietary Selenium Deficiency ... More >> Dietary Zinc Deficiency Less << Not Applicable Completed - Brazil ... More >> Onofre Lopes University Hospital Natal, Rio Grande do Norte, Brazil, 59.012.300 Less <<
NCT02434497 Homozygous Familial Hyperchole... More >>sterolemia (HoFH) Less << Phase 3 Completed - Belgium ... More >> Research Site Brussels (Woluwé-St-Lambert), Belgium, 1200 Canada, Quebec Research Site Chicoutimi, Quebec, Canada, G7H 7K9 Denmark Research Site Copenhagen, Denmark, DK-2100 Israel Research Site Halfa, Israel, 31096 Malaysia Research Site Kubang Kerian, Malaysia, 16150 Taiwan Research Site Taipei City, Taiwan, 11217 Less <<
NCT02434497 - Completed - -
NCT01971606 A Total of 234 Patients With A... More >>cute Coronary Syndrome Who Will Undergo OPCAB. Less << Phase 4 Completed - Korea, Republic of ... More >> Division of Cardiovascular Surgery, Severance Cardiovascular Hospital , Yonsei University College of Medicine Seoul, Korea, Republic of, 120-752 Less <<
NCT02117453 ANCA-associated Primary Necrot... More >>izing Vasculitides Less << Phase 3 Active, not recruiting April 2020 France ... More >> Hopital Cochin Paris, France, 75014 Less <<
NCT00240305 Metabolic Syndrome ... More >> Dyslipidemia Less << Phase 3 Completed - Australia, Western Australia ... More >> Research Site Perth, Western Australia, Australia Less <<
NCT01245894 Myocardial Infarction [C14.907... More >>.585.500] Less << Phase 4 Completed - Denmark ... More >> Department of Cardiology, Odense University Hospital Odense, Fuenen, Denmark, 5000 Less <<
NCT02234882 HIV Infections Phase 1 Completed - -
NCT01548157 Healthy Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT00206310 Heart Failure Phase 3 Completed - -
NCT02140489 Healthy Phase 1 Unknown August 2014 Korea, Republic of ... More >> Samgsung Seoul Hospital Recruiting Seoul, Korea, Republic of Principal Investigator: JaeWook Ko, M.D. Less <<
NCT00473655 - Completed - -
NCT00241488 Hypercholesterolemia Phase 3 Completed - China ... More >> Beijing, China Ching Qing, China Guang Zhou, China Harbin, China Ji Nan, China Nanjing, China Shanghai, China Shenyang, China Wu Han, China Hong Kong New Territories, Hong Kong Korea, Republic of Busan, Korea, Republic of Cheonan-si, Korea, Republic of Daegu, Korea, Republic of Ilsan, Korea, Republic of Incheon-Si, Korea, Republic of Kwangju, Korea, Republic of Pusan, Korea, Republic of Pyungchon Kyonggi, Korea, Republic of Seoul, Korea, Republic of Suwon, Korea, Republic of Wonju, Korea, Republic of Malaysia Kuching, Sarawak, Malaysia Bandar Sunway, Selangor, Malaysia Shah Alam, Selangor, Malaysia Kuala Lumpur, Malaysia Penang, Malaysia Petaling Jaya, Malaysia Seberang Perai Utara, Malaysia Taiwan Chunghua City, Taiwan Kaohsiung, Taiwan Taichung City, Taiwan Taipei, Taiwan Tao-Yuan, Taiwan Thailand Bangkok, Thailand Less <<
NCT03532139 Ovarian Cancer Phase 2 Recruiting May 31, 2024 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02214 Contact: Rachel P Rosovsky, MD       RPROSOVSKY@PARTNERS.ORG    Principal Investigator: Rachel P. Rosovsky, MD          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Jeffrey Zwicker, MD    617-975-7454    jzwicker@bidmc.harvard.edu    Principal Investigator: Jeffrey Zwicker, MD Less <<
NCT01223625 Endothelial Dysfunction ... More >> Atherosclerosis Less << Phase 4 Completed - Denmark ... More >> Department of Cardiology, Odense University Hospital Odense, Fuenen, Denmark, 5000 Less <<
NCT00396240 Primary Hypercholesterolaemia Phase 4 Withdrawn(study cancelled prio... More >>r to FSI) Less << - -
NCT03245229 Healthy Subjects Phase 1 Completed - Czechia ... More >> Cepha s.r.o Plzen, Czechia, 32300 Less <<
NCT03526367 Contrast-induced Acute Kidney ... More >>Injury ST Elevation Myocardial Infarction Primary PCI Rosuvastatin Hydration Less << Phase 4 Not yet recruiting December 31, 2019 China, Liaoning ... More >> The General Hospital of Shenyang Millitary Region Not yet recruiting Shenyang, Liaoning, China Contact: Yaling Han, MD    +86-024-28856123    hanyaling@263.net    Contact: Yi Li, MD    +86-024-28897309    doctorliyi@126.com Less <<
NCT00979121 - Terminated(stopped for futilit... More >>y) Less << - -
NCT01203982 ST-segment Elevation Myocardia... More >>l Infarction Subclinical Carotid Atherosclerosis Less << Phase 4 Completed - Denmark ... More >> Department of Cardiology, Odense University Hospital Odense, Fuenen, Denmark, 5000 Less <<
NCT00979121 Sepsis Acute ... More >>Lung Injury Less << Phase 3 Terminated(stopped for futilit... More >>y) Less << - -
NCT01021488 Deep Vein Thrombosis ... More >> Venous Thrombosis Prevention Less << Phase 4 Unknown March 2012 Korea, Republic of ... More >> Hallym University Sacred Heart Hospital, Department of Cardiology and Orthopedic Surgery Recruiting Anyang-si, Gyeonggi-do, Korea, Republic of, 431-070 Contact: Sang-Ho Jo, MD    82-31-380-3722    sophi5@medimail.co.kr    Contact: mikyung Baek    82-31-380-1975    mikyungb@hallym.or.kr Less <<
NCT03516955 - Completed - -
NCT03540355 Dyslipidemias Phase 3 Not yet recruiting January 30, 2020 -
NCT02371603 Anaemia Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT03527069 Hypertriglyceridemia ... More >> Dyslipidemia Less << Phase 3 Not yet recruiting January 30, 2020 -
NCT00970606 Acute Respiratory Distress Syn... More >>drome Influenza H1N1 Influenza Less << Not Applicable Terminated(Inability to recrui... More >>t participants since H1N1 epidemic resolved.) Less << - -
NCT02704702 - Completed - -
NCT02704702 Hypertension Phase 1 Completed - -
NCT02749994 Hypercholesterolemia Phase 3 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00347217 - Completed - -
NCT02458755 Stroke Intrac... More >>ranial Atherosclerosis Less << Phase 4 Unknown June 2018 Korea, Republic of ... More >> Oh Young Bang Recruiting Seoul, Korea, Republic of, 135-710 Contact: Oh Young Bang, MD, PhD    +82-2-3410-3599    ohyoungbang@samsung.com    Contact: Jong-Won Chung, MD, Msc    +82-10-9032-9906    neurocjw@gmail.com Less <<
NCT03395470 Metabolic Disease Phase 1 Completed - United Kingdom ... More >> Hammersmith Medicines Research (HMR) London, United Kingdom Less <<
NCT02600520 Chronic Periodontitis Phase 2 Phase 3 Completed - -
NCT00970606 - Terminated(Inability to recrui... More >>t participants since H1N1 epidemic resolved.) Less << - -
NCT00728780 Adverse Events ... More >> Pharmacokinetic Variables Less << Phase 1 Completed - United States, Indiana ... More >> Site Reference ID/Investigator# 11101 Evansville, Indiana, United States, 47710 Less <<
NCT00866229 Systemic Lupus Erythematosus ... More >> High LDL Cholesterol Level Less << Phase 4 Unknown June 2010 Thailand ... More >> Faculty of Medicine, Ramathibodi Hospital, Mahidol University Recruiting Bangkok, Thailand, 10240 Contact: Pintip Ngamjanyaporn, M.D.    +6622011477    pintiptip@yahoo.com    Contact: Piyaporn Sirijanchun, M.D.    +6622011477    tepsrc@mahidol.ac.th    Principal Investigator: Parawee Suwannalai, M.D. Less <<
NCT01033955 Critically Ill ... More >> H1N1/Influenza Infection Less << Phase 2 Terminated(H1N1 pandemic concl... More >>uded in early 2010) Less << - Canada, British Columbia ... More >> Vancouver General Hospital Vancouver, British Columbia, Canada, V5Z 1M9 St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Manitoba Health Sciences Centre Winnipeg, Manitoba, Canada, R3B 0Z3 Canada, Ontario St. Joseph's Healthcare Hamilton, Ontario, Canada, L8N 4A6 Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Mount Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 Canada, Quebec Hopital Laval Quebec City, Quebec, Canada, G1V 4G5 Centre hospitalier universitaire de Sherbrooke (CHUS) Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT00526721 - Completed - Korea, Republic of ... More >> Research Site Seoul, Jongro-gu, Korea, Republic of Research Site Seoul, Kangnam-gu, Korea, Republic of Research Site Seoul, Songpa-gu, Korea, Republic of Less <<
NCT00240344 - Completed - -
NCT03742544 - Enrolling by invitation October 30, 2020 -
NCT02854527 Healthy Phase 1 Completed - Germany ... More >> Boehringer Ingelheim Pharma GmbH & Co KG Biberach, Germany, 88397 Less <<
NCT00396110 - Completed - -
NCT02854527 - Completed - -
NCT02913794 - Unknown March 30, 2018 Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Dong-Hoon Choie       cdhlyj@yuhs.ac Less <<
NCT01415466 Healthy Phase 1 Completed - Korea, Republic of ... More >> Yonsei University Health System (Yuhs) Seoul, Korea, Republic of Less <<
NCT00526708 - Completed - Korea, Republic of ... More >> Research Site Seoul, Jongro-gu, Korea, Republic of Research Site Seoul, Kangnam-gu, Korea, Republic of Research Site Seoul, Songpa-gu, Korea, Republic of Less <<
NCT00184951 HIV Infections ... More >> Hyperlipidemia Less << Phase 2 Completed - Germany ... More >> University of Bonn Bonn, Germany University of Cologne Cologne, Germany Netherlands University of Amsterdam Amsterdam, Netherlands University of Leiden Leiden, Netherlands University of Nijmegen Nijmegen, Netherlands Less <<
NCT01200836 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01582165 Angina Pectoris Phase 4 Completed - Norway ... More >> Oslo University Hospital, Dep of Cardiology, Rikshospitalet Oslo, Norway, 0380 Less <<
NCT00526552 - Completed - Korea, Republic of ... More >> Research Site Seoul, Jongro-gu, Korea, Republic of Research Site Seoul, Kangnam-gu, Korea, Republic of Research Site Seoul, Songpa-gu, Korea, Republic of Less <<
NCT00525824 - Completed - -
NCT02561845 - Withdrawn October 2015 -
NCT03571087 Primary Hypercholesterolemia Phase 3 Completed - -
NCT00525824 Hypercholesterolemia ... More >> Coronary Heart Disease Atherosclerosis Less << Phase 3 Completed - United States, Tennessee ... More >> Research Site Brentwood, Tennessee, United States Argentina Research Site Buenos Aires, Argentina Brazil Research Site Sao Paulo, SP, Brazil Chile Research Site Santiago, Chile Colombia Research Site Brentwood, Colombia Lithuania Research Site Brentwood, Lithuania Netherlands Research Site Zwinderen, Netherlands Peru Research Site Lima, San Isidro Lima, Peru Venezuela Research Site Brentwood, Venezuela Less <<
NCT02205775 Stable Coronary Artery Disease... More >> Undergoing PCI Less << Phase 3 Terminated(difficult recruitme... More >>nt) Less << - Italy ... More >> SS. Annunziata Hospital Chieti, CH, Italy, 66100 Fondazione IRCCS Policlinico S. Matteo Pavia, PV, Italy, 27100 A.O. S. Anna e S. Sebastiano - II Università di Napoli Caserta, Italy, 81100 Azienda ASL 6 - P. Ospedaliero Livorno Livorno, Italy, 57100 Ospedale Civile G. Fornaroli Magenta, Italy, 20013 Azienda Ospedaliera - Ospedale San Paolo Milano, Italy, 20142 Less <<
NCT00233649 - Completed - -
NCT01823900 Healthy Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01352897 - Completed - Singapore ... More >> Research Site Singapore, Singapore Less <<
NCT00826358 Healthy Phase 1 Completed - United States, Florida ... More >> Site Reference ID/Investigator# 13441 Orlando, Florida, United States, 32809 Less <<
NCT00574782 - Completed - -
NCT00837083 - Completed - -
NCT03311841 Renal Insufficiency Phase 1 Completed - United States, Florida ... More >> Clinical Pharmacology of Miami ( Site 0001) Hialeah, Florida, United States, 33014 Orlando Clinical Research Center ( Site 0002) Orlando, Florida, United States, 32809 Less <<
NCT01494090 Hip Fracture Phase 3 Terminated(Decision of the Ste... More >>ering Committee. Recruitment more difficult and slower than expected.) Less << - France ... More >> Brest, University Hospital Brest, France Caen, University Hospital Caen, France Grenoble, University Hospital Grenoble, France APHP - Cochin Hospital Paris, France Quimper Hospital Quimper, France St-Etienne, University Hospital St-Etienne, France Less <<
NCT03757390 Healthy Subjects Phase 1 Recruiting December 14, 2018 Korea, Republic of ... More >> Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Less <<
NCT01953835 Systemic Lupus Erythematosus Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT00808678 Healthy Phase 1 Completed - United States, Florida ... More >> Site Reference ID/Investigator# 14762 Orlando, Florida, United States, 32809 Less <<
NCT03363815 Heathy Volunteer Phase 1 Not yet recruiting February 23, 2018 United States, Florida ... More >> Covance Clinical Research Unit Not yet recruiting Daytona Beach, Florida, United States, 32117 Less <<
NCT01914432 Hyperlipidemia ... More >> Hypertension Less << Phase 3 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT01816997 Diabetes Phase 4 Recruiting December 2022 Taiwan ... More >> Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 11217 Contact: Harn-Shen Chen, MD, PhD    886-2-28757515       Principal Investigator: Harn-Shen Chen, MD, PhD Less <<
NCT01051401 Cardiovascular Complications ... More >> Recurrent Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Less << Phase 1 Terminated(slow accrual) - United States, North Carolina ... More >> Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less <<
NCT03639493 Healthy Male Subjects Phase 1 Completed - Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of Less <<
NCT02087540 Hypertension ... More >>Hyperlipidemia Less << Phase 3 Unknown - Korea, Republic of ... More >> The Catholic University of Saint Mary's Hosiptal Recruiting Seoul, Korea, Republic of Contact: wook-seong chung, MD       chungws@catholic.ac.kr    Principal Investigator: wook-seong Chung, MD Less <<
NCT01544309 Hypercholesterolemia With Conc... More >>omitant Type 2 Diabetes Less << Not Applicable Completed - -
NCT01178853 - Completed - -
NCT01178853 Healthy Phase 4 Completed - United States, Texas ... More >> Austin, Texas, United States Less <<
NCT01881971 HIV Seropositivity Early Phase 1 Completed - United States, California ... More >> University of California, Los Angelos Los Angeles, California, United States, 90095 University of California, SF San Francisco, California, United States, 94118 United States, Pennsylvania University of Pittsburgh department of medicine division of Pulmonary, Allergy and Critical Care medicine Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00549653 Atherosclerosis ... More >> Cardiovascular Disease Less << Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Dallas, Texas, United States, 75247 Less <<
NCT01544309 - Completed - -
NCT01660191 Hypercholesterolemia Phase 4 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00388596 Osteoporosis Phase 1 Completed - United States, Florida ... More >> GSK Investigational Site Miami, Florida, United States, 33169 Less <<
NCT00783042 Atherosclerosis ... More >> Inflammatory Activity in Coronary Arteries Less << Early Phase 1 Completed - Sweden ... More >> Research Site Goteborg, Sweden Less <<
NCT01660191 - Completed - -
NCT00693589 Cardiovascular Disease ... More >> Endothelial Dysfunction Less << Phase 2 Completed - -
NCT00296387 Acute Coronary Syndrome Phase 3 Completed - -
NCT02445352 Primary Hypercholesterolemia Phase 3 Completed - Korea, Republic of ... More >> Severance Hospital Seodaemun-gu, Seoul, Korea, Republic of, 120-752 Less <<
NCT03329729 - Recruiting January 30, 2019 Greece ... More >> Agia Olga Hospital Recruiting Athens, Greece Contact: Sotirios Patsilinakos, MD Less <<
NCT02707224 Healthy Phase 1 Completed - -
NCT02089399 Healthy Phase 1 Completed - Korea, Republic of ... More >> Samsung medical center Seoul, Korea, Republic of Less <<
NCT02841774 HIV Infection ... More >> Coronary Heart Disease Less << Phase 2 Recruiting March 2019 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Matthew Feinstein, MD       matthewjfeinstein@northwestern.edu    Principal Investigator: Matthew Feinstein, MD Less <<
NCT00934258 - - - -
NCT03009487 Hypertension ... More >>Hyperlipidemias Less << Phase 3 Recruiting - Korea, Republic of ... More >> Seoul national university bundang hospital Recruiting Seoul, Korea, Republic of Contact: Wan Huh    +82-2-550-8106    whuh408@daewoong.co.kr Less <<
NCT00923676 Sexual Dysfunction ... More >> Hyperlipidemia Less << Phase 4 Unknown April 2016 Italy ... More >> Department of Geriatrics and Metabolic Diseases Naples, Italy, 80138 Less <<
NCT02561884 Healthy Phase 1 Unknown October 2015 -
NCT01773512 Coronary Artery Disease Phase 4 Unknown June 2015 United States, Illinois ... More >> Loyola University Hospital Active, not recruiting Maywood, Illinois, United States, 60153 United States, Iowa The University of Iowa Active, not recruiting Iowa City, Iowa, United States, 52242 Czech Republic General University Hospital Recruiting Prague, Czech Republic, 12808 Contact: Tomas Kovarnik, MD, PhD    +420224962687    tomas.kovarnik@vfn.cz    Contact: Jan Horak, MD, PhD    +420224962605    jan.horak@vfn.cz    Principal Investigator: Tomas Kovarnik, MD, PhD          Sub-Investigator: Jan Horak, MD, PhD          Sub-Investigator: Hana Skalicka, MD, PhD          Sub-Investigator: Ales Kral, MD, PhD          Sub-Investigator: Ales Linhart, MD, professor          Sub-Investigator: Pavel Martasek, MD, professor Less <<
NCT03434613 Nonalcoholic Fatty Liver Disea... More >>se Dyslipidemias Less << Phase 4 Not yet recruiting September 1, 2019 Korea, Republic of ... More >> Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes center Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Yong-ho Lee, M.D., Ph.D.    82-2-2228-1943    yholee@yuhs.ac Less <<
NCT00446940 Hepatitis C Phase 2 Completed - United States, Oklahoma ... More >> VA Hospital OKlahoma City, Oklahoma, United States, 73104 Less <<
NCT01660919 Hypercholesterolemia Phase 4 Completed - Korea, Republic of ... More >> Gil Medical Center Incheon, Korea, Republic of, 405-760 Less <<
NCT00336336 Heart Failure Phase 3 Completed - -
NCT01697735 Dyslipidemias Phase 4 Terminated(Because of lack of ... More >>participants and funds) Less << - China, Zhejiang ... More >> Second Hospital of Wenzhou Medical College Wenzhou, Zhejiang, China, 325000 Less <<
NCT02129231 Oxidative Stress ... More >> Diabetic Polyneuropathy Less << Phase 2 Completed - Mexico ... More >> Cardiovascular Research Unit Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT01598363 Healthy Volunteers Phase 1 Completed - United States, Wisconsin ... More >> Spaulding Clinical Research, LLC West Bend, Wisconsin, United States, 53095 Less <<
NCT02251847 Hypercholesterolemia Phase 3 Unknown - Korea, Republic of ... More >> Gil Medical Center Recruiting Seoul, Korea, Republic of Contact: Tae Hoon Ahn Less <<
NCT02105623 Coronary Arteriosclerosis Phase 4 Terminated(Slow enrollement, L... More >>ow Follow-up rate) Less << - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT02748057 Hypercholesterolemia ... More >> Familial Hypercholesterolemia Less << Phase 3 Completed - -
NCT02748057 - Completed - -
NCT00654537 Hypercholesterolemia Phase 3 Completed - -
NCT01730053 Hypercholesterolemia Phase 3 Completed - -
NCT02516826 Coronary Syndrome Phase 2 Unknown August 2018 Korea, Republic of ... More >> Cardiac and Vascular Center; Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT01730053 - Completed - -
NCT00329173 Hypercholesterolaemia Phase 3 Completed - -
NCT00296400 Hyperlipidemia Phase 2 Completed - -
NCT03009474 Hypertension ... More >>Hyperlipidemias Less << Phase 1 Completed - Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of Less <<
NCT02569814 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Inje University Busan Paik Hospital Busan, Korea, Republic of Less <<
NCT02477514 Skin Diseases, Bacterial Phase 1 Completed - -
NCT02546648 Atherosclerotic Disease ... More >> Perioperative Bleeding Less << Phase 3 Completed - Canada, Ontario ... More >> Hamilton General Hospital Hamilton, Ontario, Canada, L8L 2X2 Juravinski Hospital Hamilton, Ontario, Canada, L8V 1C3 Less <<
NCT00862251 Cardiovascular Disorder ... More >> Diabetes Mellitus Less << Phase 3 Completed - -
NCT00862251 - Completed - -
NCT02789475 Hypertension ... More >>Hyperlipidemias Less << Phase 1 Unknown July 2016 Korea, Republic of ... More >> Inha university hospital Recruiting Jung-gu, Incheon, Korea, Republic of, 400-711 Contact: Chul woo Kim, Ph.D.       cwkim1805@inha.ac.kr Less <<
NCT01382472 ST Elevation (STEMI) Myocardia... More >>l Infarction Less << Phase 4 Unknown December 2016 Norway ... More >> Stavanger University Hospital Recruiting Stavanger, Norway, 4068 Contact: Alf Inge Larsen, MD, PhD    +4751513201    laai@sus.no    Principal Investigator: Noreen Butt, MD          University Hospital of North Norway Recruiting Tromsø, Norway, NO-9038 Contact: Terje Steigen, MD, PhD    +4791507766    terje.steigen@unn.no    Principal Investigator: Terje Steigen, MD PhD          St. Olavs Hospital Not yet recruiting Trondheim, Norway, NO-7006 Contact: Rune Wiseth, MD, PhD    +4772573000    rune.wiseth@ntnu.no    Principal Investigator: Rune Wiseth, MD, PhD Less <<
NCT01153334 ST-segment Elevation AMI Phase 4 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT00296400 - Completed - -
NCT00296374 Diabetes Mellitus Phase 2 Completed - -
NCT00654602 Dyslipidaemia Phase 3 Completed - -
NCT01493856 Healthy Volunteers Phase 1 Completed - Korea, Republic of ... More >> Yonsei University Health System (Yuhs) Seoul, Korea, Republic of Less <<
NCT01288742 Hepatitis C Virus Phase 1 Completed - -
NCT02231931 Healthy Phase 1 Completed - Germany ... More >> 352.2082.1 Boehringer Ingelheim Investigational Site Biberach, Germany Less <<
NCT00296374 - Completed - -
NCT03174041 Healthy Participants Phase 1 Completed - United States, Florida ... More >> Covance Research Unit - Daytona Daytona Beach, Florida, United States, 32117 United States, Indiana Covance Clinical Research Unit Inc.; Covance Gfi Research Evansville, Indiana, United States, 47710 United States, Wisconsin Covance Clinical Research Unit, Inc Madison, Wisconsin, United States, 53704 Less <<
NCT03288038 Hypercholesterolemia Phase 3 Completed - Korea, Republic of ... More >> Chungbuk National University Hospital Cheongju-si, Korea, Republic of Yeungnam University Medical Center Daegu, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Dongguk University Ilsan Hospital Goyang-si, Korea, Republic of Hallym University Dongtan Sacred Heart Hospital Hwaseong-si, Korea, Republic of Gachon University Gil Medical Center Incheon, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of Seoul National University Bundang Hospital Seongnam-si, Korea, Republic of Boramae Hospital Seoul, Korea, Republic of Chung-Ang University Hospital Seoul, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Hanyang University Hospital Seoul, Korea, Republic of Kangbuk Samsung Hospital Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of KyungHee University Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Soon Chun Hyang University Hospital Seoul Seoul, Korea, Republic of Ajou University Hospital Suwon-si, Korea, Republic of Wonju Severance Christian Hospital Wŏnju, Korea, Republic of Less <<
NCT00214617 Hypercholesterolemia Phase 4 Completed - United States, Georgia ... More >> Atlanta Research and Education Foundation Decatur, Georgia, United States, 30033 Less <<
NCT00965315 - - - -
NCT00214604 Hyperlipoproteinemia Type III Phase 3 Completed - Norway ... More >> Research Site Oslo, Norway South Africa Research Site Cape Town, South Africa Less <<
NCT00117494 Hyperlipidemia ... More >> HIV Infections Less << Phase 4 Completed - France ... More >> service de Médecine Interne Hopital Hotel Dieu Paris, France, 75004 Less <<
NCT00654225 Hypercholesterolemia ... More >> Dyslipidaemia Less << Phase 3 Completed - -
NCT01010516 Dyslipidemia Phase 4 Unknown - Greece ... More >> University of Ioannina Medical School Recruiting Ioannina, Greece, 45 110 Contact: M S Elisaf, MD    +302651007509    egepi@cc.uoi.gr    Principal Investigator: Moses S Elisaf, MD          Sub-Investigator: Evangelos N Liberopoulos, MD          Sub-Investigator: Anastazia Kei, MD Less <<
NCT02518503 - Completed - -
NCT00680082 - Completed - -
NCT03011775 Adverse Effect ... More >> Atherosclerosis, Coronary Insulin Resistance Syndrome Less << Phase 4 Completed - Ukraine ... More >> Ukrainian Medical Stomatological Academy Poltava, Ukraine, 36011 Less <<
NCT01105325 - Terminated(due to poor patient... More >> recruitment) Less << March 2011 -
NCT00718796 Cardiovascular Disease Phase 3 Completed - Canada, Ontario ... More >> Canadian College of Naturopathic Medicine Toronto, Ontario, Canada, M2K 1E2 Less <<
NCT02305355 Diabetes Mellitus, Type 2 ... More >> Hypertriglycemia Less << Phase 4 Completed - Korea, Republic of ... More >> Bucheon St. Mary's Hospital Bucheon, Korea, Republic of Less <<
NCT02378064 Inflammation Plaque, Atheroscl... More >>erotic Coronary Disease Renin-Angiotensin System Less << Phase 4 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT01350141 Hypercholesterolemia ... More >> Dyslipidemia Less << Phase 2 Completed - -
NCT00730132 - Completed - -
NCT01350141 - Completed - -
NCT00730132 - Completed - -
NCT00874757 - Unknown December 2011 United States, Nebraska ... More >> UNMC College of Pharmacy Recruiting Omaha, Nebraska, United States, 68198-6045 Contact: Timothy R McGuire, Pharm.D.    402-559-8224    trmcguir@unmc.edu    Contact: Paul Dobesh, Pharm.D.    402-559-1983    pdobesh@unmc.edu Less <<
NCT00557778 - Completed - Brazil ... More >> Research Site Campinas, Sao Paulo, Brazil Less <<
NCT03355027 Atherosclerosis ... More >> Cardiovascular Diseases Less << Not Applicable Recruiting May 8, 2019 United Kingdom ... More >> Addenbrooke's Hospital Recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Contact: Paul Cacciottolo    01223256653    pjc99@medschl.cam.ac.uk    Principal Investigator: Joseph Cheriyan, MBChB, MA, FRCP Less <<
NCT01901757 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT01764295 Hypertension ... More >>Dyslipidemia Less << Phase 3 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00930670 Coronary Artery Disease Phase 4 Completed - Canada, Quebec ... More >> Institut Universitaire de Cardiologie et de Pneumologie de Quebec Quebec City, Quebec, Canada, G1V4G5 Less <<
NCT03719820 - Recruiting June 30, 2021 China, Beijing ... More >> Beijing Hospital Not yet recruiting Beijing, Beijing, China, 100010 Contact: Tao Gong    13718907701    gb20598@sina.com    Beijing Tongren Hospital Capital Medical University Not yet recruiting Beijing, Beijing, China, 100010 Contact: Jiawei Wang    18811612263    wangjwcq@1163.com    Beijing Anzhen Hospital Capital Medical University Not yet recruiting Beijing, Beijing, China, 100020 Contact: Guangzhi Liu    13391777952    guangzhi2002@hotmali.com    Beijing Chao-Yang hospital Not yet recruiting Beijing, Beijing, China, 100020 Contact: Wenli Hu    13552983366    huwenli@sina.com    China-Japan Friendship Hospital Not yet recruiting Beijing, Beijing, China, 100020 Contact: Dantao Peng    13910908579    18513415053@163.com    Beijing Friendship Hospital Capital Medical University Not yet recruiting Beijing, Beijing, China, 100032 Contact: Yongbo Zhang    13552909549    ybzhangcn@sina.com    Peking University First Hospital Not yet recruiting Beijing, Beijing, China, 100032 Contact: Yining Huang    13910432166    ynhuang@sina.com    General Hospital of Chinese Armed Police Forces Recruiting Beijing, Beijing, China, 100039 Contact: Shiwen Wu, MD    13910238117    neurowu@gmail.com    Peking Union Medical College Hospital Not yet recruiting Beijing, Beijing, China, 100730 Contact: Weihai Xu, MD    010-69156372    xuwh@pumch.cn    Peking University International Hospital Not yet recruiting Beijing, Beijing, China, 102200 Contact: Xianzeng Liu    13911879817    liuxianzeng@pkuih.edu.cn    China, Fujian Fujian Medical University Union Hospital Not yet recruiting Fuzhou, Fujian, China, 350001 Contact: Changyun Liu, MD    13365910778    13365910778@139.com    China, Guangdong The Third Affiliated Hospital of Sun Yat-sen University Not yet recruiting Guangzhou, Guangdong, China, 510630 Contact: Zhengqi Lu    13570102668    lzq1828@aliyun.com    The University of HongKong-Shenzhen Hospital Not yet recruiting Shenzhen, Guangdong, China, 518000 Contact: Xiaofan Chu       chuxf@hku-szh.org    China, Hebei Tangshan Gongren Hospital Recruiting Tangshan, Hebei, China, 063000 Contact: Baoquan Lu    13930565557    balcom@163.com    China, Hubei Tongji Hospital, Huazhong University of Science and Technology Not yet recruiting Wuhan, Hubei, China, 430000 Contact: Daishi Tian       tiands@foxmail.com    China, Hunan The First Affiliated Hospital of University of South China Not yet recruiting Hengyang, Hunan, China, Hunan Contact: Yong You, MD    13974709033    youy_usc@qq.com    China, Jiangsu Subei People's Hospital of Jiangsu Province Not yet recruiting Yangzhou, Jiangsu, China, 225001 Contact: Jun Xu, MD    18051061768    13611572068@126.com    China, Liaoning General Hospital of Shen Yang Millitary Command Not yet recruiting Shenyang, Liaoning, China, 110840 Contact: Huishen Chen, MD    13352452086    chszh@aliyun.com    China, Shandong JiNing NO.1 People Hospital Not yet recruiting Jining, Shandong, China, 272000 Contact: Zhongrui Yan    18678769700    zhongruiy@163.com    Qingdao Municipal Hospital Not yet recruiting Qingdao, Shandong, China, 266000 Contact: Jintai Yu       yu-jintai@163.com    Qilu Hospital of Shandong University (Qingdao) Not yet recruiting Qingdao, Shandong, China, 266555 Contact: Haifeng Li    18561810375    drlhf@163.com    China, Shanghai Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200050 Contact: Jun Liu       jly0520@hotmail.com    Tongren Hospital, Shanghai Jiaotong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200050 Contact: Ailian Du       lotusdu@126.com    China, Sichuan West China Hospital of Sichuan University Not yet recruiting Chengdu, Sichuan, China, 610000 Contact: Bo Wu       dr.bowu@hotmail.com Less <<
NCT03772262 Interaction Drug Food Early Phase 1 Recruiting March 31, 2019 United States, Washington ... More >> Washington State University Recruiting Spokane, Washington, United States, 99202 Contact: Malathi Jandhyala    509-335-3668    irb@wsu.edu Less <<
NCT00850460 Statin Adverse Reaction Phase 4 Terminated(Investigator left i... More >>nstitution and no PI has been found to continue the study) Less << - United States, New York ... More >> Rockefeller University New York, New York, United States, 10065 Less <<
NCT00850460 - Terminated(Investigator left i... More >>nstitution and no PI has been found to continue the study) Less << - -
NCT03372785 Chronic Total Occlusion of Cor... More >>onary Artery Percutaneous Coronary Intervention Coronary Artery Disease Viable Myocardium Less << Phase 4 Enrolling by invitation December 2020 China ... More >> Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University Beijing, China Less <<
NCT02767401 Hibernation, Myocardial ... More >> Complete Occlusion of Coronary Artery Less << Phase 4 Unknown December 2018 -
NCT02984982 Hypercholesterolemia ... More >> Acute Coronary Syndrome Less << Phase 4 Completed - Japan ... More >> Investigational Site Number 392026 Bunkyoku-ku, Japan Investigational Site Number 392022 Chiyoda-ku, Japan Investigational Site Number 392032 Fujisawa-shi, Japan Investigational Site Number 392004 Fukui-shi, Japan Investigational Site Number 392007 Fukuoka-shi, Japan Investigational Site Number 392048 Fukuoka-shi, Japan Investigational Site Number 392008 Gifu-shi, Japan Investigational Site Number 392039 Hiroshima-shi, Japan Investigational Site Number 392028 Isehara-shi, Japan Investigational Site Number 392036 Itabashi-ku, Japan Investigational Site Number 392037 Itabashi-ku, Japan Investigational Site Number 392024 Izumisano-shi, Japan Investigational Site Number 392013 Izunokuni-shi, Japan Investigational Site Number 392020 Kawaguchi-shi, Japan Investigational Site Number 392041 Kisarazu-shi, Japan Investigational Site Number 392009 Kitakyushu-shi, Japan Investigational Site Number 392034 Kitakyushu-shi, Japan Investigational Site Number 392044 Kochi-shi, Japan Investigational Site Number 392002 Kumamoto-shi, Japan Investigational Site Number 392011 Kumamoto-shi, Japan Investigational Site Number 392003 Kurashiki-shi, Japan Investigational Site Number 392018 Matsuyama-shi, Japan Investigational Site Number 392021 Morioka-shi, Japan Investigational Site Number 392017 Nagakute-shi, Aichi, Japan Investigational Site Number 392047 Nagaoka-shi, Japan Investigational Site Number 392038 Nagoya-shi, Japan Investigational Site Number 392042 Nagoya-shi, Japan Investigational Site Number 392033 Okayama-shi, Japan Investigational Site Number 392006 Osaka-shi, Japan Investigational Site Number 392010 Osaka-shi, Japan Investigational Site Number 392045 Osaka-shi, Japan Investigational Site Number 392046 Osaka-shi, Japan Investigational Site Number 392015 Sagamihara-shi, Japan Investigational Site Number 392019 Sakai-shi, Japan Investigational Site Number 392035 Sapporo-shi, Japan Investigational Site Number 392001 Tenri-shi, Japan Investigational Site Number 392016 Toyoake-shi, Japan Investigational Site Number 392025 Tsukuba-shi, Japan Investigational Site Number 392040 Tsukuba-shi, Japan Investigational Site Number 392005 Wakayama-shi, Japan Investigational Site Number 392027 Yokohama-shi, Japan Investigational Site Number 392043 Yokohama-shi, Japan Less <<
NCT01699126 Sleep Apnea, Obstructive Phase 4 Completed - Taiwan ... More >> Chang Gang Memorial Hospital Taoyuan, Taiwan, 333 Less <<
NCT01342211 Hypercholesterolemia ... More >> Dyslipidemia Less << Phase 2 Completed - -
NCT03561298 Healthy Subjects Phase 1 Completed - United States, Florida ... More >> Covance Clinical Research Unit Daytona Beach, Florida, United States, 32117 Less <<
NCT01342211 - Completed - -
NCT03552432 Coronary Artery Disease ... More >> Thin-cap fIbroatheroma Less << Phase 4 Recruiting September 30, 2021 Japan ... More >> Kobe University Graduate School of Medicine, Department of Cardiology Recruiting Kobe, Hyogo, Japan, 650-0017 Contact: Hiromasa Otake, MD    +81783825846    hotake@med.kobe-u.ac.jp Less <<
NCT02390375 Hypercholesterolemia Phase 3 Completed - Korea, Republic of ... More >> Boramae Hospital Seoul, Dongjak-gu, Korea, Republic of, 156-707 Less <<
NCT03720366 Leukemia, Myeloid, Acute Phase 1 Not yet recruiting December 30, 2022 -
NCT02586129 Dyslipidemia ... More >>Type II Diabetes Less << Phase 3 Completed - Korea, Republic of ... More >> Seoul National Universitiy Bundang Hospital Seongnam-Si, Gyeonggi-Do, Korea, Republic of, 463-707 Less <<
NCT01623921 Blunt Chest Trauma ... More >> Acute Respiratory Distress Syndrome Less << Not Applicable Unknown August 2013 Israel ... More >> Tel Aviv Sourasky Medical Center Not yet recruiting Tel Aviv, Israel, 64239 Contact: Avi A Weinbroum, MD    3-6973237 ext 972    draviw@tasmc.health.gov.il Less <<
NCT02114697 Atherosclerosis Phase 4 Terminated(The study was stopp... More >>ed when the original principal investigator moved to a new institution.) Less << - United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT02579499 Coronary Artery Diseasse Phase 4 Recruiting March 2022 Korea, Republic of ... More >> Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: MYEONG-KI HONG, MD, Ph.D    82-2-2228-8460    MKHONG61@yuhs.ac Less <<
NCT02814500 Healthy Phase 1 Unknown September 2016 -
NCT03418974 Dyslipidemias Phase 4 Active, not recruiting December 31, 2021 China, Beijing ... More >> Heart Center of Peking University People's Hospital Beijing, Beijing, China, 100044 China, Shanghai School of Public Health, Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT01955759 Patients With Coronary Artery ... More >>Disease Scheduled for by Pass Surgery Less << Early Phase 1 Unknown February 2015 Bosnia and Herzegovina ... More >> Heart Center BH Not yet recruiting Tuzla, TK, Bosnia and Herzegovina, 75000 Contact: Enes Osmanović    +387 66 725 744    osmanovic@bih.net.ba Less <<
NCT02586155 Diabetes Mellitus, Type 2 ... More >> Coronary Artery Disease Cardiovascular Diseases Less << Phase 3 Recruiting October 2018 Israel ... More >> Lady Davis Carmel Medical Center Recruiting Haifa, Israel, 34362 Contact: Basil Lewis, MD Less <<
NCT02740699 Cardiovascular Disease Phase 4 Recruiting December 15, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02114697 - Terminated(The study was stopp... More >>ed when the original principal investigator moved to a new institution.) Less << - -
NCT02449187 Diabetes Hype... More >>rlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Inha University Hospital Incheon, Korea, Republic of Less <<
NCT03532854 Healthy Male Volunteers Phase 1 Not yet recruiting September 18, 2018 Korea, Republic of ... More >> LG chem Not yet recruiting Seoul, Gangseo-Gu, Korea, Republic of, 07795 Contact: Subin Lee    02-6987-4153    leesubin@lgchem.com Less <<
NCT00240357 Hypercholesterolemia Phase 4 Withdrawn(Study cancelled prio... More >>r to FSI) Less << - -
NCT02549846 Ischemic Stroke Phase 4 Completed - Japan ... More >> Hyogo collage of Medicine Nishinomiya, Hyogo, Japan, 665-8501 Less <<
NCT03136237 Hereditary Angioedema Phase 1 Completed - United Kingdom ... More >> Covance CRU Leeds, United Kingdom, LS2 9LH Less <<
NCT00371501 Atherosclerosis ... More >> Thromboembolism Systemic Lupus Erythematosus Less << Phase 4 Completed - Hong Kong ... More >> Tuen Mun Hospital Hong Kong, Hong Kong Less <<
NCT02785874 HCC Not Applicable Terminated(insufficient for th... More >>e fund) Less << - Taiwan ... More >> WanFangHospital Taipei, Taiwan, 116 Less <<
NCT02977065 Dyslipidemias Phase 2 Completed - Australia ... More >> Not provided Adelaide, Australia Less <<
NCT03210532 Hypertension ... More >>Dyslipidemia Less << Phase 3 Completed - Korea, Republic of ... More >> Sevrance Hospital Seoul, Korea, Republic of Less <<
NCT02592317 Prostatic Neoplasms, Castratio... More >>n-Resistant Less << Phase 1 Active, not recruiting August 1, 2019 Moldova, Republic of ... More >> Chisinau, Moldova, Republic of Spain Barcelona, Spain Sevilla, Spain Less <<
NCT01489943 Crohn's Disease Phase 1 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT01634906 Hyperlipidemia ... More >> Atherosclerosis Less << Not Applicable Completed - Netherlands ... More >> Sint Franciscus Gasthuis Rotterdam, Zuid Holland, Netherlands, 3004 BA Less <<
NCT03550859 Chronic Kidney Disease ... More >> Proteinuria Less << Phase 4 Not yet recruiting June 2019 Korea, Republic of ... More >> Korea University Ansan Hospital Not yet recruiting Ansan, Korea, Republic of Less <<
NCT02770261 Hypertension ... More >>Cholesterolemia Less << Phase 3 Completed - Korea, Republic of ... More >> Korea University Guro Hospital Seoul, Korea, Republic of Less <<
NCT00090298 Hypercholesterolemia Phase 3 Completed - -
NCT01624857 Coronary Heart Disease Phase 3 Unknown June 2014 China, Beijing ... More >> China National Center for Cardiovascular Diseases Recruiting Beijing, Beijing, China, 100037 Contact: Zhe Zheng, M.D., Ph.D.    8610-8839-6051    zhengzhefuwai@tom.com    Principal Investigator: Zhe Zheng, M.D., Ph.D. Less <<
NCT00767130 - Unknown December 2009 United States, California ... More >> University of California-San Francisco Recruiting San Francisco, California, United States, 94110 Contact: Alan H.B. Wu, PhD    (415) 206-3540    wualan@labmed2.ucsf.edu    Principal Investigator: Alan H.B. Wu, PhD          United States, Connecticut Hartford Hospital Recruiting Hartford, Connecticut, United States, 06102 Contact: Richard L. Seip, PhD    860-545-5005    rseip@harthosp.org    Principal Investigator: Paul D. Thompson, M.D.          United States, New York Rogosin Institute, New York Presbyterian Hospital Recruiting New York, New York, United States, 10021 Contact: Chioma Okoro    212-702-9600 ext 105    cokoro@mail.rockefeller.edu    Contact: Bruce Gordon, M.D.          Principal Investigator: Bruce Gordon, M.D. Less <<
NCT02709187 Healthy Phase 1 Completed - -
NCT00464503 Statin Induced Proteinuria Not Applicable Completed - Belgium ... More >> University of Antwerp Antwerp, Belgium, 2610 Less <<
NCT02741245 Hypercholesterolemia Phase 3 Completed - -
NCT02741245 - Completed - -
NCT01173939 Hypercholesterolemia ... More >> Type 2 Diabetes Hypertension Less << Not Applicable Terminated(With recommendation... More >> from IDMC, Steering Committee terminated this trial due to ethical concerns raised by J-ART study.) Less << - -
NCT00854503 Type 2 Diabetes ... More >> Diabetic Dyslipidemia Less << Phase 3 Completed - Italy ... More >> University of Rome Tor Vergata Rome, Italy, 00133 Less <<
NCT00300430 Dyslipidemia ... More >>Coronary Heart Disease Mixed Dyslipidemia Less << Phase 3 Completed - United States, Illinois ... More >> Global Medical Information North Chicago, Illinois, United States, 60064 Less <<
NCT00300430 - Completed - -
NCT02428374 Myocardial Fibrosis Phase 4 Recruiting July 2019 Brazil ... More >> Hospital Sao Paulo - UNIFESP Recruiting Sao Paulo, Brazil, 04040001 Contact: Francisco A H Fonseca, MD, PhD    +5511992639082    fahfonseca@terra.com.br Less <<
NCT02968160 Metabolic Syndrome Phase 4 Recruiting July 2018 Korea, Republic of ... More >> Dongguk University Medical Center Recruiting Ilsan, Korea, Republic of, 10326 Less <<
NCT03255044 Heart Failure Phase 4 Recruiting May 2019 Egypt ... More >> Ain Shams University Hospital Cardiology Rehab Unit Recruiting Cairo, Egypt Contact: Hazem Khorshid, PhD    +201227442219    hazemkhorshid@yahoo.com    Principal Investigator: Nouran Omar, MSc Less <<
NCT02401256 Healthy Phase 4 Completed - United States, Indiana ... More >> Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 Less <<
NCT02401256 - Completed - -
NCT02612714 Sexual Dysfunction Phase 4 Completed - Taiwan ... More >> Chang Gung Kaohsiung, Taiwan, 83349 Less <<
NCT00462748 - Completed - -
NCT02411903 Cerebral Infarction ... More >> Clopidogrel,Poor Metabolism of (Disorder) Less << Phase 4 Unknown August 2016 -
NCT00462748 Hypercholesterolemia Phase 3 Completed - -
NCT01105975 Dyslipidemia Phase 2 Completed - -
NCT02901067 Wounds and Injuries ... More >> Venous Thromboembolism Less << Phase 2 Recruiting December 2021 United States, Colorado ... More >> Denver Health Medical Center Recruiting Denver, Colorado, United States, 80204 Principal Investigator: Ernest E. Moore, M.D. Less <<
NCT00987974 Ischemia Reperfusion Injury ... More >> Endothelial Dysfunction Less << Phase 4 Completed - Netherlands ... More >> RUNMC Nijmegen, Netherlands, 6500HB Less <<
NCT01870466 Healthy Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01023607 Coronary Artery Disease ... More >> Hyperlipidemia Less << Phase 4 Completed - China, Heilongjiang ... More >> The Second Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China, 150081 Less <<
NCT01105975 - Completed - -
NCT01730040 - Completed - -
NCT01730040 Hypercholesterolemia Phase 3 Completed - -
NCT00487318 Chronic Hepatitis C Phase 2 Completed - United States, Oklahoma ... More >> Veterans Administration Medical Center Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT03044665 Cardiovascular Diseases ... More >> Cerebrovascular Disease Peripheral Atherosclerotic Disease Less << Not Applicable Recruiting February 15, 2022 Korea, Republic of ... More >> Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 03722 Contact: Yang-Soo Jang, MD, PhD Less <<
NCT02008786 Coronary Artery Dissection, Sp... More >>ontaneous Less << Phase 4 Recruiting June 2021 Canada, British Columbia ... More >> Vancouver General Hospital Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Tara L Sedlak, MD    604-875-5487    Tara.Sedlak@vch.ca    Principal Investigator: Jacqueline Saw, MD          Principal Investigator: Tara Sedlak, MD Less <<
NCT01011127 - Completed - Korea, Republic of ... More >> Gil Medical Center Incheon, Korea, Republic of, 405-760 Less <<
NCT02685462 Healthy Phase 1 Completed - United States, Florida ... More >> Miami, Florida, United States Less <<
NCT00479713 Hypercholesterolemia Phase 3 Completed - -
NCT03521700 Renal Artery Obstruction ... More >> Stents Lipids Glomerular Filtration Rate Blood Pressure Less << Phase 2 Phase 3 Completed - China, Beijing ... More >> Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing, China, 010 Less <<
NCT03515772 - Recruiting October 31, 2019 Switzerland ... More >> Universitätsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Catia Marzolini, PhD    +41 77 454 92 28    Catia.Marzolini@usb.ch    Centre Hospitalier Universitaire Vaudois (CHUV) Recruiting Lausanne, Switzerland, 1011 Contact: Perrine Courlet    +41 21 314 42 60    perrine.courlet@chuv.ch Less <<
NCT00719693 Pharmacokinetic Variables Phase 1 Completed - United States, Indiana ... More >> Site Reference ID/Investigator# 9242 Evansville, Indiana, United States, 47710 Less <<
NCT00479713 - Completed - -
NCT02933658 Hypertension and Dyslipidemia Phase 1 Completed - -
NCT02730689 Healthy Volunteers Phase 1 Completed - -
NCT01420549 Hypercholesterolemia ... More >> Dyslipidemia Less << Phase 3 Completed - Brazil ... More >> Universidade Federal de São Paulo São Paulo, Brazil, 040249000 Less <<
NCT01154036 Hypercholesterolemia Phase 3 Completed - -
NCT00262548 Diabetes Mellitus, Type 2 Phase 4 Completed - Mexico ... More >> Research site Cuernavaca, Morelos, Mexico Less <<
NCT01154036 - Completed - -
NCT00491530 Mixed Dyslipidemia Phase 3 Completed - United States, Illinois ... More >> Medical Information Specialist Abbott Park, Illinois, United States, 60064 Less <<
NCT03307252 Healthy Phase 1 Completed - Germany ... More >> CTC North GmbH & Co. KG, Hamburg Hamburg, Germany, 20251 Less <<
NCT00811356 Malaria Phase 1 Terminated(safety issues (toxi... More >>city)) Less << - Australia, Victoria ... More >> GSK Investigational Site Melbourne, Victoria, Australia, 3004 Less <<
NCT00115830 Atherosclerosis Phase 3 Completed - United States, Massachusetts ... More >> Brigham and Womens Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00978419 - Completed - -
NCT00978419 Burns Phase 2 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00871351 Primary Hypercholesterolemia Phase 4 Completed - -
NCT00491530 - Completed - -
NCT00871351 - Completed - -
NCT03474562 ASCVD Impaire... More >>d Fasting Glucose Hypertension Less << Phase 4 Not yet recruiting October 2019 Korea, Republic of ... More >> Dankook University Hospital Not yet recruiting Cheonan, Korea, Republic of CHA Bundang Medical Center Not yet recruiting Seongnam, Korea, Republic of Gangnam Severance Hospital Not yet recruiting Seoul, Korea, Republic of Severance Hospital Not yet recruiting Seoul, Korea, Republic of Less <<
NCT00781560 - Completed - China, Beijing ... More >> Research Site Beijing, Beijing, China China, Guangdong Research Site Chenzhen, Guangdong, China Research Site Guangzhou, Guangdong, China China, Heilongjiang Research Site Harbin, Heilongjiang, China China, Henan Research Site ZhengZhou, Henan, China China, Jiangsu Research Site Nanjing, Jiangsu, China China, Liaoning Research Site Shenyang, Liaoning, China China, Shandong Research Site Jinan, Shandong, China Research Site Qingdao, Shandong, China China, Shanghai Research Site Shanghai, Shanghai, China China, Shanxi Research Site Xi'an, Shanxi, China China, Sichuan Research Site Chengdu, Sichuan, China China, Tianjin Research Site Tianjin, Tianjin, China China, Zhejiang Research Site Hangzhou, Zhejiang, China Reseearch Site Ningbo, Zhejiang, China Less <<
NCT00468923 Cardiovascular Disease ... More >> Stroke Less << Phase 4 Completed - Canada, Ontario ... More >> Hamilton General Hospital Hamilton, Ontario, Canada, L8L 2X2 Less <<
NCT03113994 Spinal Cord Injuries ... More >> Osteoporosis Metabolic Syndrome Less << Phase 2 Recruiting December 2020 United States, Florida ... More >> University Of Miami Miller School of Medicine Not yet recruiting Miami, Florida, United States, 33136 Contact: Luisa Betancourt, MD, MS    305-243-6320    lbetancourt@med.miami.edu    Principal Investigator: Mark S Nash, Ph.D., FACSM          Canada, Ontario University Health Network - Toronto Rehab Lyndhurst Centre Recruiting Toronto, Ontario, Canada, M4G 3V9 Contact: Masae Miyatani, PhD    416-597-3422 ext 6304    masae.miyatani@uhn.ca    Contact: Lindsie Blencowe, MSc    416-597-3422 ext 6301    lindsie.blencowe@uhn.ca    Principal Investigator: Cathy Craven, BA, MD, MSc, FRCPC, CCD Less <<
NCT02665832 Healthy Phase 1 Unknown June 2016 -
NCT01567826 Coronary Artery Disease Phase 4 Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT01567826 - Completed - -
NCT00681395 Adverse Events ... More >> Pharmacokinetic Less << Phase 1 Completed - United States, Florida ... More >> Site Reference ID/Investigator# 8089 Orlando, Florida, United States, 32809 Less <<
NCT03536598 Hypertension With Hyperlipidem... More >>ia Less << Phase 3 Completed - -
NCT03738761 Hypertension Phase 4 Recruiting April 2019 Armenia ... More >> Unimed medical center Not yet recruiting Abovyan, Armenia Center of Preventive Cardiology Not yet recruiting Yerevan, Armenia Croatia Thalassotherapia Opatija, Specijalna bolnica za medicinsku rehabilitaciju, bolesti srca, pluća i reumatizma, Klinika za liječenje, rehabilitaciju i prevenciju bolesti srca i krvnih žila Recruiting Opatija, Croatia KBC Rijeka - Sušak, Klinika za internu medicinu, Zavod za nefrologiju, dijalizu i transplantaciju bubrega Recruiting RIjeka, Croatia KB Dubrava, Klinika za unutarnje bolesti, Zavod za nefrologiju i dijalizu Recruiting Zagreb, Croatia KB Merkur, Klinika za unutarnje bolesti, Zavod za kardiologiju Recruiting Zagreb, Croatia KBC Sestre milosrdnice, Klinika za bolesti srca i krvnih žila, Zavod za bolesti krvnih žila Recruiting Zagreb, Croatia KBC Zagreb, Klinika za bolesti srca i krvnih žila Recruiting Zagreb, Croatia KBC Zagreb, Klinika za unutarnje bolesti, Zavod za nefrologiju, arterijsku hipertenziju, dijalizu i transplantaciju Recruiting Zagreb, Croatia Poliklinika za prevenciju kardiovaskularnih bolesti i rehabilitaciju SRČANA Recruiting Zagreb, Croatia Hungary Biatros Kft. Recruiting Biatorbágy, Hungary AD SANITATEM Bt. Recruiting Pilisvörösvár, Hungary Poland Przychodnia Kardiologiczna w Zespole Przychodni Specjalistycznych DIAB-END-COR Active, not recruiting Krakow, Poland Niepubliczny Zakład Opieki Zdrowotnej Neuromed M.i M. Nastaj Spółka Partnerska Recruiting Lublin, Poland Poradnia Kardiologiczna, Nowodworskie Centrum Medyczne Active, not recruiting Nowy Dwór Mazowiecki, Poland Poradnia Kardiologiczna Samodzielnego Publicznego Zespołu Zakładów Opieki Zdrowotnej im. Marszałka Józefa Piłsudskiego w Płońsku Active, not recruiting Płońsk, Poland Poradnia Kardiologiczna w Niepublicznym Zakładzie Opieki Zdrowotnej Euro-Klinika Sp. z o.o. w Siemianowicach Śląskich Active, not recruiting Siemianowice Śląskie, Poland Poradnia internistyczno-kardiologiczna w Niepublicznym Zakładzie Opieki Zdrowotnej AURUM Active, not recruiting Warsaw, Poland Poradnia Kardiologiczna w Przychodni Rejonowej - Specjalistycznej (III) Samodzielnego Zespołu Publicznych Zakładów Lecznictwa Otwartego Warszawa - Ochota Recruiting Warsaw, Poland Przychodnia ACTIV-MED. Recruiting Warsaw, Poland Russian Federation Federal State Budgetary Scientific Institution "Scientific Research Institute of Complex Problems of Cardiovascular Diseases" Recruiting Kemerovo, Russian Federation Federal State budget organization National medical research center of cardiology of the Ministry of healthcare of the Russian Federation Recruiting Moscow, Russian Federation State Budgetary Institution of Healthcare of Moscow "City Clinical Hospital № 29 named after N.E. Bauman of Department of Healthcare of Moscow city" (SBIH "CCH № 29 Bauman") Not yet recruiting Moscow, Russian Federation Federal State Budgetary Institution "V.A. Almazov National Medical Research Center" of the Ministry of Health of the Russian Federation (V.A. Almazov NMRC) Recruiting Saint Petersburg, Russian Federation Federal State Budgetary Educational Institution Higher Education "Volgograd State Medical University" of the Ministry of Healthcare of the Russian Federation (FSBEI HE VolgSMU MOH Russia) Not yet recruiting Volgograd, Russian Federation Serbia Klinički centar Srbije Recruiting Belgrade, Serbia Klinički centar Niš Recruiting Niš, Serbia Inštitut za kardiovaskularne bolesti Vojvodine Recruiting Sremska Kamenica, Serbia Slovenia Univerzitetna klinika za pljučne bolezni in alergijo Golnik Recruiting Golnik, Slovenia Splošna bolnišnica Jesenice Recruiting Jesenice, Slovenia Zdravstveni Zavod CELJENJE Recruiting Koper, Slovenia Ordinacija interne medicine Verboten Kopriva Renata Recruiting Litija, Slovenia Cardial, d. o. o. Recruiting Ljubljana, Slovenia MC Medicor, d. d. Recruiting Ljubljana, Slovenia Intermed, d. o. o. Recruiting Maribor, Slovenia Srce in ožilje, d. o. o. Recruiting Maribor, Slovenia Less <<
NCT01644188 Hypercholesterolemia Phase 3 Completed - -
NCT01023503 - Withdrawn(Changes affecting Po... More >>st Authorization Study Regulatory effective from Dec09, impacted the requirements for Spanish studies at National and Regional level.) Less << July 2012 Spain ... More >> Research Site Barcelona, Spain Less <<
NCT01563731 Stroke Transi... More >>ent Ischemic Attack Hypertension Less << Phase 4 Recruiting November 2018 Russian Federation ... More >> Almazov Federal Heart, Blood and Endocrinology Centre Recruiting Saint-Petersburg, Russian Federation, 197341 Less <<
NCT00256750 - Completed - -
NCT01890967 Hypercholesterolemia Phase 2 Completed - -
NCT01047683 Hypertriglyceridemia Phase 3 Completed - -
NCT01890967 - Completed - -
NCT00256750 Kidney Transplantation ... More >> Chronic Kidney Failure Less << Phase 3 Completed - -
NCT01047501 Hypertriglyceridemia Phase 3 Completed - -
NCT01455935 Stroke Phase 2 Unknown February 2014 United States, New York ... More >> Millard Fillmore Gates Circle Hospital Recruiting Buffalo, New York, United States, 14209 Contact: Annemarie Crumlish    716-887-5548    acrumlish@thejni.org    Principal Investigator: Tareq Kass-Hout, MD          Principal Investigator: Elad Levy, MD          Sub-Investigator: Adnan H Siddiqui, MD,PhD          Sub-Investigator: Kenneth V Snyder, MD, PhD          Sub-Investigator: L N Hopkins, MD          Sub-Investigator: Robert N Sawyer, MD          Sub-Investigator: Marilou Ching, MD          Sub-Investigator: David Janicke, MD Less <<
NCT00132717 Hypercholesterolemia Phase 3 Completed - -
NCT02107898 Hypercholesterolemia Phase 3 Completed - Japan ... More >> Investigational Site Number 392016 Adachi-Ku, Japan Investigational Site Number 392029 Adachi-Ku, Japan Investigational Site Number 392024 Aki-Gun, Japan Investigational Site Number 392012 Chuo-Ku, Japan Investigational Site Number 392013 Chuo-Ku, Japan Investigational Site Number 392032 Fukui-Shi, Japan Investigational Site Number 392004 Hakusan-Shi, Japan Investigational Site Number 392028 Kaga-Shi, Japan Investigational Site Number 392002 Kanazawa-Shi, Japan Investigational Site Number 392005 Kanazawa-Shi, Japan Investigational Site Number 392023 Kawanishi-Shi, Japan Investigational Site Number 392009 Kisarazu-Shi, Japan Investigational Site Number 392026 Kitakyushu-Shi, Japan Investigational Site Number 392003 Komatsu-Shi, Japan Investigational Site Number 392011 Kuki-Shi, Japan Investigational Site Number 392017 Matsumoto-Shi, Japan Investigational Site Number 392007 Mito-Shi, Japan Investigational Site Number 392006 Moriya-Shi, Japan Investigational Site Number 392018 Nagoya-Shi, Japan Investigational Site Number 392014 Oota-Ku, Japan Investigational Site Number 392019 Osaka-Shi, Japan Investigational Site Number 392020 Osaka-Shi, Japan Investigational Site Number 392022 Osaka-Shi, Japan Investigational Site Number 392030 Osaka-Shi, Japan Investigational Site Number 392027 Oyabe-Shi, Japan Investigational Site Number 392010 Saitama-Shi, Japan Investigational Site Number 392015 Shinjuku-Ku, Japan Investigational Site Number 392031 Shizuoka-Shi, Japan Investigational Site Number 392021 Suita-Shi, Japan Investigational Site Number 392025 Takamatsu-Shi, Japan Investigational Site Number 392008 Tsuchiura-Shi, Japan Investigational Site Number 392001 Yamagata-Shi, Japan Less <<
NCT01644188 - Completed - -
NCT01492361 Cardiovascular Diseases Phase 3 Completed - -
NCT01507831 Hypercholesterolemia Phase 3 Completed - -
NCT02107898 - Completed - -
NCT01507831 - Completed - -
NCT01617655 - Completed - -
NCT02072161 Hypercholesterolemia Phase 2 Completed - -
NCT01617655 Hypercholesterolaemia Phase 3 Completed - -
NCT01644175 Hypercholesterolemia Phase 3 Completed - -
NCT02289963 Hypercholesterolemia Phase 3 Completed - Korea, Republic of ... More >> Investigational Site Number 410009 Anyang-Si, Korea, Republic of, 431-070 Investigational Site Number 410001 Anyang, Korea, Republic of, 431-070 Investigational Site Number 410017 Busan, Korea, Republic of, 602-715 Investigational Site Number 410007 Busan, Korea, Republic of, 614-735 Investigational Site Number 410002 Daegu, Korea, Republic of, 700-712 Investigational Site Number 410011 Goyang-Si, Korea, Republic of, 410-773 Investigational Site Number 410003 Gwangju, Korea, Republic of, 501-757 Investigational Site Number 410012 Incheon, Korea, Republic of, 405-760 Investigational Site Number 410018 Jeonju-Si, Korea, Republic of, 561-712 Investigational Site Number 410006 Seoul, Korea, Republic of, 06591 Investigational Site Number 410004 Seoul, Korea, Republic of, 07061 Investigational Site Number 410015 Seoul, Korea, Republic of, 08308 Investigational Site Number 410008 Seoul, Korea, Republic of, 110-746 Investigational Site Number 410005 Seoul, Korea, Republic of, 134-727 Investigational Site Number 410010 Seoul, Korea, Republic of, 152-703 Investigational Site Number 410013 Ulsan, Korea, Republic of Taiwan Investigational Site Number 158007 Changhua, Taiwan, 500 Investigational Site Number 158005 Hsinchu, Taiwan, 30071 Investigational Site Number 158011 Kaohsiung, Taiwan, 807 Investigational Site Number 158010 Kaohsiung, Taiwan, 833 Investigational Site Number 158006 Taichung, Taiwan Investigational Site Number 158009 Tainan Hsien, Taiwan, 710 Investigational Site Number 158008 Tainan, Taiwan, 704 Investigational Site Number 158001 Taipei, Taiwan, 100 Investigational Site Number 158003 Taipei, Taiwan, 104 Investigational Site Number 158002 Taipei, Taiwan, 112 Investigational Site Number 158004 Taoyuan Hsien, Taiwan Less <<
NCT01623115 - Completed - -
NCT02289963 - Completed - -
NCT01623115 Hypercholesterolemia Phase 3 Completed - -
NCT00812955 Dyslipidemia, Hypercholesterol... More >>emia, Hypertriglyceridemia Less << Phase 3 Completed - -
NCT03510715 Hypercholesterolemia Phase 3 Recruiting June 2020 United States, California ... More >> Investigational Site Number 8400004 Recruiting Los Angeles, California, United States, 90027 Austria Investigational Site Number 0400001 Recruiting Wien, Austria, 1090 Brazil Investigational Site Number 0760001 Recruiting Sao Paulo, Brazil, 05403-000 Canada Investigational Site Number 1240002 Recruiting Montreal, Canada, H3T 1C5 Investigational Site Number 1240001 Recruiting Quebec, Canada, G1V 4W2 Denmark Investigational Site Number 2080001 Recruiting Viborg, Denmark, 8800 France Investigational Site Number 2500001 Recruiting Bron Cedex, France, 69677 Italy Investigational Site Number 3800001 Recruiting Palermo, Italy, 90127 Mexico Investigational Site Number 4840006 Recruiting Oaxaca, Mexico, 68000 Netherlands Investigational Site Number 5280001 Recruiting Amsterdam, Netherlands, 1105 AZ Norway Investigational Site Number 5780001 Recruiting Oslo, Norway, 0373 Russian Federation Investigational Site Number 6430002 Recruiting Kemerovo, Russian Federation, 650002 Slovenia Investigational Site Number 7050001 Recruiting Ljubljana, Slovenia, 1000 Spain Investigational Site Number 7240001 Recruiting A Coruna, Spain, 15001 Taiwan Investigational Site Number 1580001 Recruiting Taipei, Taiwan, 112 Turkey Investigational Site Number 7920002 Recruiting Ankara, Turkey, 06500 Investigational Site Number 7920001 Recruiting Izmir, Turkey, 35040 Less <<
NCT03510884 Hypercholesterolaemia Phase 3 Recruiting March 2022 -
NCT01926782 - Completed - -
NCT00532311 Hypercholesterolemia Phase 3 Terminated(Overall profile of ... More >>the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents) Less << - -
NCT01644175 - Completed - -
NCT03061487 - Recruiting April 27, 2018 Italy ... More >> University Magna Graecia of Catanzaro Recruiting Catanzaro, Italy, 88100 Contact: Raffaele Serra, M.D., Ph.D.    +3909613647380    rserra@unicz.it    Sub-Investigator: Stefano de Franciscis, M.D.          Sub-Investigator: Luca Gallelli, M.D.; Ph.D Less <<
NCT00812955 - Completed - -
NCT01259791 Statin Myopathy Not Applicable Completed - Canada, Ontario ... More >> St. Joseph's Health Care London, Ontario, Canada, N6A 4V2 Less <<
NCT01926782 Hypercholesterolemia Phase 3 Completed - -
NCT02386917 Obesity Not Applicable Active, not recruiting December 2019 Norway ... More >> HVestfold Tønsberg, Vestfold, Norway, 3103 Less <<
NCT00359281 Healthy Phase 2 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02551172 Hyperlipidemias Phase 3 Unknown February 2016 Korea, Republic of ... More >> Euljii General Hospital Recruiting Seoul, Korea, Republic of, 139-711 Contact: Jin-Young Jang    +82-2-970-8216    erica_37@naver.com    Principal Investigator: Kyung Ah Han, M.D., Ph.D. Less <<
NCT01954394 Hypercholesterolemia Phase 3 Completed - -
NCT00079638 Dyslipidemia ... More >>Coronary Heart Disease Atherosclerosis Stroke Diabetes Less << Phase 4 Completed - -
NCT00673660 - Completed - Turkey ... More >> Pfizer Investigational Site Mecidiyekoy, Istanbul, Turkey, 34394 Pfizer Investigational Site Bolu, Turkey Pfizer Investigational Site Haseki/Istanbul, Turkey, 34390 Pfizer Investigational Site Istanbul, Turkey, 34098 Pfizer Investigational Site Istanbul, Turkey Less <<
NCT01954394 - Completed - -
NCT01702987 Myopathy HMG ... More >>COA Reductase Inhibitor Adverse Reaction Hypercholesterolemia Less << Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00673660 - Completed - -
NCT03267329 Hypertension ... More >>Dyslipidemia Less << Phase 4 Not yet recruiting October 2018 Korea, Republic of ... More >> The Catholic University of Korea, Bucheon ST. Mary's Hospital Bucheon-si, Korea, Republic of Inje University Ilsan PAIK Hospital Goyang-si, Korea, Republic of KangBuk Samsung Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital Not yet recruiting Seoul, Korea, Republic of Yonsei University Health System, SEVERANCE HOSPITAL Seoul, Korea, Republic of Seoul National University, Bundang Hospital Sŏngnam, Korea, Republic of Wonju Severance Christian Hospital Wŏnju, Korea, Republic of Less <<
NCT02976818 - Recruiting April 2019 Canada ... More >> Institute of Nutrition and Functional Foods (INAF) Recruiting Quebec, Canada, G1V 0A6 Contact: Patrick Couture, MD, FRCP,PhD    418-654-2106    patrick.couture@crchul.ulaval.ca    Contact: André Tremblay, PhD    418-656-2131 ext 11417    andre.tremblay@fsaa.ulaval.ca    Principal Investigator: Patrick Couture, MD,FRCP,PhD          Sub-Investigator: André Tremblay, PhD Less <<
NCT01702987 - Completed - -
NCT01972178 Dyslipidemia Phase 2 Terminated - -
NCT03127631 Prostate Cancer ... More >> Cardiovascular Disease Less << Not Applicable Recruiting September 2020 Canada, British Columbia ... More >> Vancouver General Hospital Active, not recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Ontario William Osler Health System Recruiting Brampton, Ontario, Canada, L6R 3J7 Contact: Achal Sharma       achal.sharma@williamoslerhs.ca    Principal Investigator: Dr. Tamara Wallington, MD,FRCPC          St. Joseph's Healthcare Recruiting Hamilton, Ontario, Canada, L8N4A6 Contact: Aishwarya Sudakaran       sudakaran@hhsc.ca    Principal Investigator: Dr. Bobby Shayegan, MD,FRCSC          Juravinski Cancer Centre Recruiting Hamilton, Ontario, Canada, L8V1C3 Contact: Amanda Thiessen       thiessena@hhsc.ca    Principal Investigator: Dr. Jehonathan Pinthus, MD,FRCS(C),PhD          Queen's University Recruiting Kingston, Ontario, Canada, K7L 3J7 Contact: Wendy Anstey, RN       wendy.anstey@krcc.on.ca    Principal Investigator: Dr. Robert Siemens, MD,FRCSC          Grand River Hospital, Grand River Regional Cancer Centre Recruiting Kitchener, Ontario, Canada, N2G 1G3 Contact: Elyse Wellhauser       Elyse.Wellhauser@grhosp.on.ca    Principal Investigator: Darin Gopaul, MD          London Health Sciences Centre Recruiting London, Ontario, Canada, N6A 5W9 Contact: Mounirah May       mounirah.may@lhsc.ca    Principal Investigator: Dr. Patrick Luke, MD,FRCSC          London Health Sciences, Victoria Hospital Recruiting London, Ontario, Canada, N6A 5W9 Contact: Amanda Anderson       Amanda.Anderson@lhsc.on.ca    Principal Investigator: Joseph Chin, MD, FRCSC          Niagara Health, St. Catharines Site Active, not recruiting Niagara, Ontario, Canada, L2S 0A9 Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Christopher Knee, ND, MSc       cknee@ohri.ca    Principal Investigator: Dr. Luke Lavallee, MDCM,MSc,FRCSC          Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Marlene Kebabdjian       marlene.kebabdjian@sunnybrook.ca    Principal Investigator: Dr. Laurence Klotz, MD,FRCS(C)          University Health Network, Princess Margaret Cancer Centre Active, not recruiting Toronto, Ontario, Canada, M5G 2C1 Canada, Quebec University Hospital of Montreal Recruiting Montreal, Quebec, Canada, H2X 0A9 Contact: Roberta Carling       roberta-daila.carling.chum@ssss.gouv.qc.ca    Principal Investigator: Dr. Emmanuelle Duceppe, MD,FRCPC          Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Amandine Laffitte       amandine.laffitte.ccomtl@ssss.gouv.qc.ca    Principal Investigator: Dr. Tamim Niazi, MDCM          McGill University Active, not recruiting Montréal, Quebec, Canada, H3A 0G4 Laval University Recruiting Quebec City, Quebec, Canada, G1V 0A6 Contact: Denise St-Onge       denise.st-onge@crchudequebec.ulaval.ca    Principal Investigator: Dr. Vincent Fradet, MD,PhD,FRCSC Less <<
NCT01444326 Cardiovascular Disease Not Applicable Completed - Canada ... More >> Institute of Nutraceutical and Functional Foods (INAF), Laval University Quebec, Canada, G1V 0A6 Less <<
NCT01436123 Coronary Artery Disease ... More >> Atherosclerosis Less << Phase 1 Terminated(The study was termi... More >>nated under the political pressure of the Federal Security Service of the Russian Federation (FSB) and the Russian Society of Cardiology) Less << - Netherlands ... More >> De Haar Research Foundation Rotterdam, South Holland, Netherlands, 3071PR Russian Federation Ural Center of Modern Nanotechnologies, Institute of Natural Sciences, Ural Federal University Yekaterinburg, Sverdlovsk oblast, Russian Federation, 620000 Ural Institute of Cardiology Yekaterinburg, Sverdlovsk oblast, Russian Federation, 620144 Less <<
NCT00359281 - Completed - -
NCT00360217 Hypertriglyceridemia (TG>200<5... More >>00) Hyperlipidemia Coronary Artery Disease Coronary Risk Equivalent Diabetes Less << Not Applicable Completed - United States, Maine ... More >> Maine Center for Lipids and Cardiovascular Health Scarborough, Maine, United States, 04074 Less <<
NCT03533959 - Recruiting December 2025 Japan ... More >> Kobe University Graduate School of Medicine, Department of Cardiology Recruiting Kobe, Hyogo, Japan, 650-0017 Contact: Hiromasa Otake, MD    +81783825846    hotake@med.kobe-u.ac.jp Less <<
NCT00261352 Type 2 Diabetes Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT03121521 Hepatopathy Phase 4 Completed - -
NCT01274559 Primary Hypercholesterolemia ... More >> Mixed Dyslipidemia Less << Phase 3 Terminated(In HPS2-THRIVE, MK-... More >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs) Less << - -
NCT01274559 - Terminated(In HPS2-THRIVE, MK-... More >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs) Less << - -
NCT01257971 - Completed - Croatia ... More >> Research Site Biograd na moru, Croatia Research Site Bjelovar, Croatia Research Site Cakovec, Croatia Research Site Crikvenica, Croatia Research Site Dubrovnik, Croatia Research Site Gospic, Croatia Research Site Karlovac, Croatia Research Site Koprivnica, Croatia Research Site Krapina, Croatia Research Site Krapinske toplice, Croatia Research Site Opatija, Croatia Research Site Osijek, Croatia Research Site Porec, Croatia Research Site Pula, Croatia Research Site Rijeka, Croatia Research Site Sisak, Croatia Research Site Slavonski brod, Croatia Research Site Split, Croatia Research Site Stubicke toplice, Croatia Research Site Umag, Croatia Research Site Vinkovci, Croatia Research Site Virovitica- Slatina, Croatia Research Site Virovitica, Croatia Research Site Vukovar, Croatia Research Site Zadar, Croatia Research Site Zageb, Croatia Research Site Zagreb, Croatia Less <<
NCT00726362 - Completed - Taiwan ... More >> Research Site Changhua, Taiwan Research Site Hualien, Taiwan Research Site Kaohsiung, Taiwan Research Site Pingtung, Taiwan Research Site Taichung, Taiwan Research Site Tainan, Taiwan Research Site Taipei, Taiwan Research Site Yun-Lin, Taiwan Less <<
NCT01483950 - Completed - Bosnia and Herzegovina ... More >> Research Site Banja Luka, Bosnia and Herzegovina Research Site Bijeljina, Bosnia and Herzegovina Research Site Doboj, Bosnia and Herzegovina Reserach Site Gradiška, Bosnia and Herzegovina Research Site Kakanj, Bosnia and Herzegovina Research Site Maglaj, Bosnia and Herzegovina Research Site Prijedor, Bosnia and Herzegovina Research Site Sarajevo, Bosnia and Herzegovina Research Site Tešanj, Bosnia and Herzegovina Research Site Trebinje, Bosnia and Herzegovina Research Site Visoko, Bosnia and Herzegovina Research Site Zavidovići, Bosnia and Herzegovina Research Site Zenica, Bosnia and Herzegovina Research Site Zvornik, Bosnia and Herzegovina Less <<
NCT00125125 Dyslipidemia Phase 4 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00127218 Atherosclerosis ... More >> Cardiovascular Disease Less << Phase 3 Completed - United States, Maryland ... More >> Johns Hopkins Unversity School of Medicine Baltimore, Maryland, United States, 21218 Less <<
NCT00127218 - Completed - -
NCT00251680 Type 2 Diabetes Phase 3 Completed - -
NCT02941848 Primary Hypercholesterolemia Phase 1 Completed - -
NCT03417388 Coronary Artery Disease Phase 4 Recruiting December 30, 2022 United States, California ... More >> Cedars-Sinai Heart Institute Recruiting Los Angeles, California, United States, 90048 Contact: Sophie Yoo, MS    310-423-3300    jihye.yoo@cshs.org    Principal Investigator: Chrisandra Shufelt, MD          LA BioMedical Recruiting Torrance, California, United States, 90502 Principal Investigator: Matthew Budoff, MD          United States, Florida Family Medicine at Eastside Community Practice Recruiting Gainesville, Florida, United States, 32206 Family Medicine at Hampton Oaks Medical Plaza (Adults and Peds) Recruiting Gainesville, Florida, United States, 32607 Internal Medicine at Tower Hill Recruiting Gainesville, Florida, United States, 32607 Family Medicine at Haile Plantation (Adults & Peds) Recruiting Gainesville, Florida, United States, 32608 Cardiovascular Clinic at UF Health UF Recruiting Gainesville, Florida, United States, 32610 Internal Medicine at UF Health Medical Plaza Recruiting Gainesville, Florida, United States, 32610 UF Health at the University of Florida Recruiting Gainesville, Florida, United States, 32610 Cardiology West at Doctors Park Recruiting Gainesville, Florida, United States, 32611 Family Medicine at 4th Ave Recruiting Gainesville, Florida, United States, 32611 Family Medicine at Old Town (Adults and Peds) Recruiting Gainesville, Florida, United States, 32680 Baptist Health Recruiting Jacksonville, Florida, United States, 32207 Principal Investigator: Ruple Galani, MD          Naval Hospital Jacksonville Recruiting Jacksonville, Florida, United States, 32214 UF Primary Care at Lake City SW Recruiting Lake City, Florida, United States, 32024 UF Primary Care at Lake City West Recruiting Lake City, Florida, United States, 32024 Novel Clinical Research Recruiting Miami, Florida, United States, 33186 Contact: Heber L Varela, MD    786-773-2737       Daytona Heart Group Recruiting Multiple Locations, Florida, United States, 32114 Contact: Glenn Rayos, MD    386-258-8722       Ocala Research Institute Inc. Recruiting Ocala, Florida, United States, 34480 Contact: Rakesh Prashad, MD    352-412-5989       Orlando Health Recruiting Orlando, Florida, United States, 32806 Principal Investigator: Arnold Einhorn, MD          Naval Hospital Pensacola Recruiting Pensacola, Florida, United States, 32512 Principal Investigator: Carrie Gray, MD          Florida Hospital Tampa - Pepin Heart Institute Recruiting Tampa, Florida, United States, 33613 Contact: Charles R Lambert, MD    813-615-7527       Interventional Cardiac Consultants Recruiting Tampa, Florida, United States, 33613 Contact: Carlos J Bayron, MD    727-842-9526       United States, Kentucky University of Kentucky Recruiting Lexington, Kentucky, United States, 40506 Principal Investigator: Gretchen Wells, MD Less <<
NCT01970215 Dyslipidemia Phase 2 Completed - Denmark ... More >> H:S Amager Hospital Copenhagen, Denmark Sydvestjysk Sygehus Esbjerg, Denmark Herlev University Hospital Herlev, Denmark Hvidovre Hospital Hvidovre, Denmark Regionshopitalet - Silkeborg Silkeborg, Denmark Netherlands EB FlevoResearch B.V Almere, Netherlands Academic Medical Centre Amsterdam-Zuidoost, Netherlands Andromed Amsterdam Amsterdam, Netherlands Andromed Leiden Amsterdam, Netherlands Andromed Breda B.V Breda, Netherlands Andromed Eindhoven Eindhoven, Netherlands Andromed Noord B.V Groningen, Netherlands Andromed Zoetermeer Leiderdorp, Netherlands Andromed Rotterdam BV Rotterdam, Netherlands Albert Schweitzer Ziekenhuis Sliedrecht, Netherlands Andromed Oost Velp, Netherlands Praktijk Zwijndrecht Zwijndrecht, Netherlands Less <<
NCT02941796 Hyperlipidemias Phase 1 Completed - Korea, Republic of ... More >> Inje University Busan Paik Hospital Busan, Korea, Republic of Less <<
NCT00309374 Endotoxemia Phase 1 Completed - Austria ... More >> Medical University of Vienna, Dept. of Clinical Pharmacology Vienna, Austria Less <<
NCT01709500 Heterozygous Familial Hypercho... More >>lesterolemia Less << Phase 3 Completed - Czech Republic ... More >> Hradec Kralove, Czech Republic Praha 2, Czech Republic Praha 5, Czech Republic Praha 8, Czech Republic Trutnov, Czech Republic Vyskov, Czech Republic Netherlands Alkmaar, Netherlands Amsterdam, Netherlands Apeldoorn, Netherlands Enschede, Netherlands Goes, Netherlands Groningen, Netherlands Hoogeveen, Netherlands Hoorn, Netherlands Rotterdam, Netherlands Sittard- Geleen, Netherlands Utrecht (2 locations), Netherlands Venlo, Netherlands Waalwijk, Netherlands Norway Oslo, Norway United Kingdom Cardiff, United Kingdom London, United Kingdom Manchester, United Kingdom Middlesex, United Kingdom Newcastle upon Tyne, United Kingdom West Bromwich, United Kingdom Less <<
NCT00664469 Hypercholesterolemia Phase 3 Terminated(Poor enrollment) - Canada, Quebec ... More >> Merck Frosst Canada Ltd. Kirkland, Quebec, Canada, H9H 3L1 Less <<
NCT01709500 - Completed - -
NCT02850081 Carotid Artery Stenosis ... More >> Strokes Less << Phase 3 Recruiting April 2022 United States, New Jersey ... More >> Valley Hospital Not yet recruiting Ridgewood, New Jersey, United States, 07450 Contact: Avery Freed    201-389-0194    afreed@valleyhealth.com    Contact: Kathleen Sayles       KSAYLES@valleyhealth.com    Principal Investigator: Dorothea Altschul, MD          United States, New York Albany Medical College/The Vascular Group at Albany Not yet recruiting Albany, New York, United States, 12208-3479 Contact: Ryan Kaim       KaimR@mail.amc.edu    Contact: Angela Sheehan       SheehaA@mail.amc.edu    Principal Investigator: Courtney Warner, MD          Sub-Investigator: Ralph C Darling, MD          State University of New York at Buffalo Not yet recruiting Buffalo, New York, United States, 14260-7016 Contact: Jennifer Gay    716-440-4231    jgay@ubns.com    Contact: Reagan O'Toole       rotoole@ubns.com    Principal Investigator: Adnan Siddiqui, MD          New York University School of Medicine Not yet recruiting New York, New York, United States, 10016-6402 Contact: Jacqueline Bott    212-263-2268    jacqueline.bott@nyumc.org    Principal Investigator: Thomas Maldonado, MD          Icahn School of Medicine at Mount Sinai Not yet recruiting New York, New York, United States, 10029 Contact: Rebecca Apruzzese    212-241-8349    rebecca.apruzzese@mountsinai.org    Contact: Milerva Santos       milerva.santos@mountsinai.org    Principal Investigator: J Mocco, MD          Sub-Investigator: Emilia Bagiella, MD          Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Rebeca Aragon Garcia, BS    212-305-4679    ra2356@cumc.columbia.edu    Contact: Josephine U Pucci, BA    21123054679    jup2102@cumc.columbia.edu    Principal Investigator: Edward S Connolly, MD          Sub-Investigator: Elise A Caccappolo Van Vliet, PhD          Sub-Investigator: Yaakov Stern, MD          Sub-Investigator: Richard Buchsbaum          Sub-Investigator: Eric J Heyer, MD          Sub-Investigator: Erin L Heinzen-Cox, PhD          Cornell University Medical College (Weill) Not yet recruiting New York, New York, United States, 10065-4805 Contact: Ruchita Mehta       rum2006@med.cornell.edu    Principal Investigator: Peter Connolly, MD Less <<
NCT02715726 Hypercholesterolemia Phase 3 Completed - -
NCT00964106 Drug Interactions Phase 1 Completed - Korea, Republic of ... More >> GSK Investigational Site Busan, Korea, Republic of, 614-735 GSK Investigational Site Seoul, Korea, Republic of, 110-744 Less <<
NCT01763866 Hyperlipidemia Phase 3 Completed - -
NCT03648788 - Not yet recruiting August 2024 -
NCT02518516 - Completed - Canada, British Columbia ... More >> Dept. of Anesthesiology, Pharmacology & Therapeutics (APT), University of British Columbia Vancouver, British Columbia, Canada, V6T 1Z3 Less <<
NCT01763866 - Completed - -
NCT00249899 Hypercholesterolemia Phase 3 Terminated(Overall profile of ... More >>the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents) Less << - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.00mL

0.20mL

0.10mL

4.99mL

1.00mL

0.50mL

9.99mL

2.00mL

1.00mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories